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Abstract
Background: The vast majority of global stillbirths occur in low- and middle-income countries,
and in many settings, the majority of stillbirths occur antenatally, prior to the onset of labour. Poor
nutritional status, lack of antenatal care and a number of behaviours increase women's risk of
stillbirth in many resource-poor settings. Interventions to reduce these risks could reduce the
resulting burden of stillbirths, but the evidence for the impact of such interventions has not yet
been comprehensively evaluated.
Methods: This second paper of a systematic review of interventions that could plausibly impact
stillbirth rates covers 12 different interventions relating to behavioural and socially mediated risk
factors, including exposures to harmful practices and substances, antenatal care utilisation and
quality, and maternal nutrition before and during pregnancy. The search strategy reviewed indexed
medical journals on PubMed and the Cochrane Library. If any eligible randomised controlled trials
were identified that were published after the most recent Cochrane review, they were added to
generate new meta-analyses. Interventions covered in this paper have a focus on low- and middle-
income countries, both because of the large burden of stillbirths and because of the high prevalence
of risk factors including maternal malnutrition and harmful environmental exposures. The reviews
and studies belonging to these interventions were graded and conclusions derived about the
evidence of benefit of these interventions.
Results: From a programmatic perspective, none of the interventions achieved clear evidence of
benefit. Evidence for some socially mediated risk factors were identified, such as exposure to
indoor air pollution and birth spacing, but still require the development of appropriate
interventions. There is a need for additional studies on culturally appropriate behavioural
interventions and clinical trials to increase smoking cessation and reduce exposure to smokeless
tobacco. Balanced protein-energy supplementation was associated with reduced stillbirth rates, but
larger well-designed trials are required to confirm findings. Peri-conceptional folic acid
supplementation significantly reduces neural tube defects, yet no significant associated reductions
in stillbirth rates have been documented. Evidence for other nutritional interventions including
Published: 7 May 2009
BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 doi:10.1186/1471-2393-9-S1-S3
<supplement> <title> <p>Stillbirths – the global picture and evidence-based solutions</p> </title> <editor>Zulfiqar A Bhutta, Gary L Darmstadt, Joy E Lawn. Guest review editor: Robert L Goldenberg.</editor> <sponsor> <note>Review and publication were supported by the Saving  Newborn Lives programme of Save the Children-US through a grant from the Bill &amp; Melinda Gates Foundation.</note> </sponsor> <note>Systematic reviews</note> <url>http://www.biomedcentral.com/content/pdf/1471-2393-9-S1-info.pdf</url> </supplement>
This article is available from: http://www.biomedcentral.com/1471-2393/9/S1/S3
© 2009 Yakoob et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
Page 2 of 35
(page number not for citation purposes)
multiple micronutrient and Vitamin A supplementation is weak, suggesting the need for further
research to assess potential of nutritional interventions to reduce stillbirths.
Conclusion: Antenatal care is widely used in low- and middle-income countries, and provides a
natural facility-based contact through which to provide or educate about many of the interventions
we reviewed. The impact of broader socially mediated behaviors, such as fertility decision-making,
access to antenatal care, and maternal diet and exposures like tobacco and indoor air pollution
during pregnancy, are poorly understood, and further research and appropriate interventions are
needed to test the association of these behaviours with stillbirth outcomes. For most nutritional
interventions, larger randomised controlled trials are needed which report stillbirths disaggregated
from composite perinatal mortality. Many antepartum stillbirths are potentially preventable in low-
and middle-income countries, particularly through dietary and environmental improvement, and
through improving the quality of antenatal care – particularly including diagnosis and management
of high-risk pregnancies – that pregnant women receive.
Introduction
The vast majority of the world's 3.2 million annual still-
births occur in low- and middle-income countries [1].
Stillbirths account for half or more of all perinatal deaths.
Globally, two-thirds to three-quarters of stillbirths may
occur antenatally, before labour begins. The rest are
largely associated with complications and/or poor care
during labour and delivery [2,3]. While intrapartum care
is associated with reductions in fresh stillbirths (deaths <
12 hours prior to delivery), the quality of care during the
antenatal period is associated with the incidence of ante-
natal stillbirths, which occur prior to the onset of labour
[4]. Depending on access to and quality of obstetric care,
as well as prevalence of antenatal risk factors, the propor-
tion of intrapartum (fresh) and antenatal (macerated)
stillbirths may vary; several studies from low-resource set-
tings in Zambia and Pakistan suggest that intrapartum
stillbirths may make up a majority of all stillbirths in
some settings. Stillbirths during pregnancy have diverse
etiologies, and while some causal pathways remain
unknown, a growing body of literature suggests that
maternal habits like smoking and other toxic exposures,
lack of adequate nutrition to the growing fetus, environ-
mental hazards, genetic abnormalities, and maternal
infections and conditions contribute to the causation of
stillbirths prior to the onset of labour [5].
Rates of stillbirth during pregnancy closely track the use
and quality of maternal health care services, being gener-
ally higher in economically poorer communities with
poor access and/or low utilisation of periconceptual and
antenatal care (ANC) services, compared with economi-
cally well-off populations with good access and high utili-
sation of quality ANC services, including monitoring and
treatment of risk factors that arise during pregnancy [2].
Hence stillbirth rates, particularly rates of stillbirths that
occur before labour begins, can be considered a proxy for
access to and quality of reproductive health and ANC serv-
ices [6].
Interventions delivered during pregnancy, particularly
those that alter maternal behaviours to improve maternal
health status, minimise fetal exposure to insult, and/or
improve utilization and quality of ANC could plausibly
prevent antenatal stillbirths, but their impact has not been
systematically reviewed and reported. To this end, this
paper examines the evidence for non-clinical interven-
tions with a biologically plausible impact on stillbirth
incidence that can be delivered via reproductive health or
ANC services before or during pregnancy, particularly
those that target socially mediated risk factors for still-
birth. Clinical interventions delivered during pregnancy
to prevent or manage maternal conditions or infections,
another large category of antenatal risk factors for still-
birth, are reviewed in the third paper in this series [7].
Because the burden of stillbirths is highest in low- and
middle-income countries, this paper focuses on interven-
tions deliverable in these countries, particularly at the
community level, as many stillbirths in these settings
occur without any contact with the formal health system,
or from care being sought too late to prevent adverse out-
comes. Although interventions included in this review are
implemented before or during pregnancy, and most inter-
ventions impact antepartum stillbirths, some of the inter-
ventions may primarily impact intrapartum stillbirths.
Methods
The literature search methodology and data extraction
and analysis process used for this paper are summarised in
paper 1 of the series [5]. In brief, we reviewed all of the
available evidence for the impact of biologically plausible
behavioural and nutrition interventions during pregnancy
on stillbirth and perinatal mortality, including systematic
reviews, peer-reviewed articles in medical journals, and
grey literature. Searches included studies published after
1980 including only human subjects, and involved both
general searches (e.g., "stillbirth", "fetal death", OR "peri-
natal mortality") and specific searches for interventions
reporting stillbirths as outcome (e.g., iron AND supple-BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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mentation AND pregnancy). Interventions implementa-
ble before and during pregnancy (prior to the onset of
labour) that were assessed in this paper to determine their
impact on stillbirth and perinatal mortality are shown in
Table 1.
A total of 130 papers (15 systematic reviews and meta-
analyses, and 115 individual studies) met the study crite-
ria and were included in this review.
Results
Family and community norms and behaviours
Prevention of female genital mutilation (FGM) and 
management of pregnant women with FGM
Background
Female genital mutilation (FGM) is comprised of all pro-
cedures that involve partial or total removal of the exter-
nal female genitalia or other injury to the female genital
organs whether for cultural or other non-therapeutic rea-
sons [8]. An estimated 140 million girls and women, pri-
marily in African countries and less commonly in Asia and
the Middle East, have undergone FGM; an estimated 2
million girls and women undergo the procedure each year
[9]. Due to increased migration from Africa, Asia, and the
Middle East, FGM has also been increasingly documented
in the US, Europe and Australia [10]. Types of FGM
include excision of the prepuce and/or partial or complete
clitoridectomy (Type I), clitoridectomy accompanied by
excision of part or all of the labia minora (Type II), exci-
sion of all of the external genitalia with infibulation (sur-
gical narrowing) of the vaginal opening (Type III), or any
pricking, piercing, stretching, or cauterisation of the clito-
ris and/or labia; or vaginal cutting, scraping, or introduc-
tion of corrosive substances into the vagina (Type IV).
Most of these procedures are irreversible [8,11] and can
cause a host of adverse immediate consequences includ-
ing infection, haemorrhage, and pain, as well as long-term
consequences including pelvic infection leading to steril-
ity, scarring, difficulty urinating, increased vulnerability to
HIV infection, and childbirth complications [12]. Particu-
larly for women with Type III FGM, there is a risk of
obstructed labour and/or severe perineal tears unless
defibulation – surgical cutting of the vaginal opening – is
performed. Very few studies, however, have examined the
association of prior FGM with adverse obstetric outcomes
such as stillbirths and perinatal deaths.
Literature-based evidence
We identified 6 relevant observational studies (Table 2). A
large, multi-centre prospective study in 6 African countries
by the WHO study group [8] monitored outcomes among
women (N = 28,393) attending obstetric centres for sin-
gleton delivery. Women were physically examined before
delivery to classify them by the World Health Organiza-
tion (WHO) system described above and then monitored
for pregnancy outcome. Compared to women without
FGM, the study found a statistically significant increased
adjusted relative risk of perinatal mortality for women
who had had FGM Type II [Relative risk (RR) = 1.32, 95%
Confidence interval (CI): 1.08–1.62] and Type III (RR =
1.55, 95% CI: 1.12–2.16). A retrospective study by Oduro
et al. [13] of hospital delivery data in Ghana (N = 5071)
found approximately double the rates of stillbirths in
mothers with FGM compared to those without (6%, 89/
1466, vs. 3%, 123/3605), but did not conduct significance
testing. In three southwest Nigerian hospitals among
women seeking family planning or ANC, Larsen et al. [14]
(N = 1851) found that women with FGM had significantly
higher risks of tearing (OR = 1.89, 95% CI: 1.04–3.41; P =
0.036) and stillbirths (OR = 1.44, 95% CI: 1.00–2.06),
although there was no significant difference between
women with Type I and Type II FGM.
Table 1: Interventions implemented before and during pregnancy or before the onset of labour reviewed in this paper
Family and community norms and behaviours
Prevention of female genital mutilation (FGM) and management of pregnant women with FGM
Birth spacing
Reduction of exposure to indoor air pollution
Smoking cessation
Reduction of exposure to smokeless tobacco
Antenatal care (ANC) in pregnancy
Nutritional support interventions
Peri-conceptional folic acid supplementation
Iron supplementation
Vitamin A/β carotene supplementation
Multivitamin/multiple micronutrient supplementation
Magnesium supplementation for deficient states
Balanced protein-energy supplementationBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Table 2: Impact of female genital mutilation (FGM) on stillbirth and perinatal mortality
Source Location, Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Observational studies
Essen et al. 2002 [15] Sweden.
Cohort of perinatal deaths (N = 
63) born in Sweden from 1990–
1996 to immigrant women from 
the Horn of Africa with FGM.
Examined the association between 
FGM and perinatal death.
Perinatal mortality rate (PMR): 
[NSa]
FGM was associated with 
obstructed and prolonged labour.
Hakim 2001 [17] Ethiopia (Addis Ababa). Hospital-
based.
Cross-sectional study of mothers 
with FGM (N = 1225) and without 
FGM (256) who had spontaneous, 
term, singleton and vertex vaginal 
deliveries in 1997 in 3 urban 
hospitals.
Assessed the impact of FGM on 
labour duration and pregnancy 
outcomes
PMR: [NS]
FGM was associated with delayed 
second stage labour among 
women with FGM (P < 0.05) and 
the first and tenth minute mean 
Apgar scores were lower for 
women with FGM (p < 0.05)
Larsen and Okonofua
2002 [14]
Nigeria (Southwest). Hospital 
setting.
Prospective cohort study of 
mothers seeking family planning or 
ANC at 3 hospitals, including 
uncircumcised women and women 
with FGM Types I and II (N = 
1851).
Examined the association of 
obstetric complications with FGM. 
Women were interviewed and had 
a medical exam, and were followed 
for pregnancy outcome.
SB: Increased risk in circumcised 
women (statistically significant).
Increased risk of tearing among 
women with FGM.
Oduro et al. 2006 [13]. Ghana (Navrongo). War Memorial 
Hospital.
Retrospective study of hospital 
deliveries from 1996 – 2003 (N = 
5071). 29% of women (N = 1466) 
with FGM.
Examined the association of FGM 
with stillbirth incidence.
SB: Incidence doubled in mothers 
with vs. mothers without FGM 
(6%; 89/1466 vs. 123/3605, 
respectively). No statistical 
significance data.
Vangen et al. 2002 [16] Norway, Medical Birth Registry of 
Norway.
Cross-sectional population-based 
registry study of all births in 
Norway from 1986–1998 to 
primarily infibulated women born 
in Somalia (N = 1733) and to 
ethnic Norwegians (N = 702192)
Compared the risk of perinatal 
complications among Somali 
women with FGM with that of 
ethnic Norwegians using univariate 
and multivariate methods.
Early neonatal death (ENND): 
Odds Ratio (OR) = 1.4 [95% 
confidence interval (CI): 0.7–3.0] 
[NS]
Antepartum SB: OR = 2.5 (95% CI: 
1.7–3.7).
Intrapartum SB: OR = 1.2 (95% CI: 
0.2–8.3) [NS]
Elevated risk in women with FGM 
of perinatal complications including 
induction of labour, fetal distress, 
secondary arrest, prolonged 2nd 
stage, and operative delivery.
World Health Organization 
(WHO) study group on female 
genital mutilation and obstetric 
outcome 2006 [8]
Burkina Faso, Ghana, Kenya, 
Nigeria, Senegal, Sudan. 28 
obstetric centres
Multi-country, multi-centre 
prospective study of women 
attending for singleton delivery (N 
= 28 393) between 2001–2003 
with various types of FGM.
Compared relative risk of stillbirth 
for women with different types of 
FGM in reference to no FGM. 
Women were examined before 
delivery for evidence of FGM and 
typed by WHO classification.
PMR:
[FGM I] OR = 1.15 [NS]
[FGM II]: OR = 1.32 (95% CI: 
1.08–1.62)
[FGM III] OR = 1.55 (95% CI: 
1.12–2.16)
compared with uncircumcised 
women (reference group).
a NS = Non-significantBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Several studies in high-income countries examined preg-
nancy outcomes among immigrants with FGM. Essen et
al. [15]  conducted  perinatal  death   audits  among  the
offspring of female immigrants to Sweden from Ethiopia,
Eritrea, and Somalia (N = 63), and found no evidence that
female circumcision was related to any cases of obstructed
labour or perinatal deaths, though the type of FGM was
not assessed. A larger retrospective study by Vangen et al.
[16] using birth registry data for the Somalia-born female
population in Norway (N = 1733) found higher rates of
many obstetric complications and perinatal death, partic-
ularly pre-labour fetal deaths [Odds ratio (OR): 2.5, 95%
CI: 1.7–3.7]. An association of FGM with pre-labour fetal
deaths has not been documented elsewhere, and the phys-
iological pathway is unclear.
One pathway by which FGM may cause perinatal mortal-
ity is by obstructing or prolonging labour. Comparing
spontaneous, term, vertex, singleton deliveries among
women with FGM (N = 1225) to those without FGM (N =
256) in urban hospitals in Ethiopia, Hakim [17] found
significant delays in the second stage of labour, and lower
one- and ten-minute mean Apgar scores among women
with FGM (p < 0.05), but perinatal mortality rates were
not significantly different.
Conclusion
The limited studies examining the impact of FGM on still-
birth and perinatal mortality are of mixed quality and
reported mixed results. Overall, the evidence suggests that
FGM is associated with increased risk of perinatal mortal-
ity or morbidity. Studies from high-income countries
likely failed to find consistent associations with perinatal
mortality because of the near-universal prevalence of facil-
ity-based births and the high quality of obstetric care in
those countries [15,16]. The only study from a low-
income country that found no evidence of an impact on
perinatal mortality [17] did not grade women based on
the degree of FGM, and did not examine stillbirths sepa-
rately, though it did lend credence to obstructed labour as
a causal pathway for stillbirth due to FGM. The largest and
most rigorous observational study [8], reported a signifi-
cant increase in risk of perinatal mortality for women with
FGM type 2 and 3, but still failed to report stillbirth and
early neonatal mortality rates separately. Only two studies
assessed the association of FGM on stillbirth rates specifi-
cally [13,14]; both found heightened stillbirth rates
among women who had had FGM, but did not control for
other variables. As women who have had FGM are likely
fundamentally to be different from women who have not
had FGM in many contexts, even controlling for all
known confounders might not effectively control for all
differences between groups. Comparing studies in high-
versus low-income countries, it appears that the quality of
obstetric care, rather than the simple provision of ANC,
may be a critical factor in whether FGM is associated with
adverse perinatal outcomes. However, all of the studies
reflect data from facility-based births. There remains a
need for rigorous studies that explore the relationships
between FGM, obstructed/prolonged labour, and still-
birth rates (rather than perinatal mortality), particularly
for births outside of health facilities.
Birth spacing
Background
Short inter-pregnancy intervals (IPI) have been identified
as a risk factor for poor pregnancy outcomes, particularly
infant mortality, in low- and middle-income countries
[18]. Excessively long IPIs (generally exceeding 6 years)
are also associated with increased risk of adverse preg-
nancy outcome. An IPI of 18–23 months was recom-
mended as ideal with respect to the risk of perinatal
outcomes by one recent study from the US [19]. Opti-
mally-spaced births have economic, social and demo-
graphic significance, and could potentially reduce fetal
and maternal morbidity and mortality. Maternal nutri-
tional depletion, competition theory (the concept that
pregnancy represents a struggle between mother and fetus
for scarce resources) and behavioural risk factors [20]
have been used to explain the relationship between short
IPIs and adverse perinatal outcomes [21]. For example,
while there is evidence that some women seek to avoid
pregnancy to recuperate after an adverse pregnancy out-
come [22], a number of demographic studies indicate that
a large proportion of women seek to become pregnant
very quickly after a lost pregnancy, even if the underlying
cause of the first adverse outcome remains unresolved
[23].
Literature-based evidence
The literature search identified no Cochrane reviews on
the subject of birth spacing that reported perinatal mortal-
ity outcomes, but 8 observational studies were identified
(Table 3). DaVanzo et al. in Bangladesh [24] considered
the type of pregnancy outcomes before and after an IPI, as
well as the duration of the IPI, controlling for socio-eco-
nomic and demographic covariates. Of the IPIs that began
with a live birth, those <6 months in duration were asso-
ciated with a 7.5-fold increase in the odds of an induced
abortion (95% CI: 6.0–9.4), a 3.3-fold increase in the
odds of a miscarriage (95% CI: 2.8–3.9), and a 1.6-fold
increase in the odds of a stillbirth (95% CI: 1.2–2.1) com-
pared with 27- to 50-month IPIs. IPIs of 6–14 months
were associated with increased odds of induced abortion
(2.0, 95% CI 1.5–2.6). IPIs ≥ 75 months were associated
with increased odds of all three adverse outcomes, but
were not as risky as very short intervals. Women were
likely to experience the same adverse outcome sequen-
tially [LOE: 2+].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Table 3: Impact of birth spacing on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirth/Perinatal outcomes
Observational studies
DaVanzo et al. 2007 [24] Bangladesh (Matlab). Population-
based study, the Matenal Child 
Health-Family Planning area.
Observational study. Pregnancy 
outcomes (N = 66,759) that 
occurred between 1982 and 2002.
Compared the impact of IPIs, 
beginning with a live birth, of < 6 
months in duration vs. 27-to 50-
month.
SBR: OR = 1.6 (95% CI: 1.2–2.1).
Induced abortion: OR = 7.5 (95% CI: 
6.0–9.4).
Miscarriage: OR = 3.3 (95% CI: 2.8–
3.9).
All three types of non-live-birth (NLB) 
outcomes: increased odds at IPIs > or 
= 75, but not as risky as very short 
intervals. IPIs that began with a NLB 
were generally more likely to end with 
the same type of NLB
Orji et al. 2004 [27] Nigeria. University Teaching 
Hospital Complex.
Comparative matched case-control 
study. N = 100 multiparae (N = 50 
cases, N = 50 controls).
Compared the impact of 
prolonged birth spacing (> or = 6 
years) (cases) vs. shorter birth 
spacing (2 – 5 years) (controls).
PMR or maternal deaths: None in 
both groups.
No significant difference in 
spontaneous onset of labour, 
induction or argumentation of labour, 
duration of labour, spontaneous 
vaginal delivery rates, Caesarean 
section rates, instrumental vaginal 
deliveries, analgesic requirement, 
postpartum hemorrhage, and Apgar 
scores in both groups.
Smith et al. 2003 [18] UK (Scotland).
Retrospective cohort study. N = 
89,143 women having second 
births in 1992–8 who conceived 
within five years of their first birth 
(N = 69,055 had a first term live 
birth).
Assessed the association between 
preceding IPI and the outcome of 
the second birth in women with a 
first term live birth after adjusting 
for different variables.
SBR or IUGR: No significant 
association.
A short IPI (< 6 months) was an 
independent risk factor for extremely 
pre-term birth (adjusted odds ratio 
2.2, 1.3 to 3.6), moderately pre-term 
birth (1.6, 1.3 to 2.0), and neonatal 
death unrelated to congenital 
abnormality (3.6, 1.2 to 10.7).
Women whose subsequent IPI was 
less than six months were more likely 
than other women to have had a first 
birth complicated by perinatal death 
(OR = 24.4, 95% CI: 18.9 to 31.5).
Stephansson et al. 2003 [25] Sweden. Nationwide study.
Retrospective evaluation of a 
national cohort.
N = 410,021 women's first and 
second singleton deliveries 
between 1983 and 1997.
Compared the impact on 
pregnancy outcomes of IPIs of 
short duration (0–3 months) vs. 
intervals between 12 and 35 
months.
SBR: OR = 1.9 (95% CI: 1.3–2.7).
Adj. OR = 1.3 (95% CI: 0.8–2.1).
Early neonatal death: OR = 1.8 (95% 
CI: 1.2–2.8).
Adj. OR = 0.9 (95% CI: 0.5–1.6).
SBR among women with IPIs of 72 
months and longer: adjusted OR = 1.5 
(95% CI: 1.1 – 2.1).
Early neonatal death among women 
with IPIs of 72 months and longer: 
adjusted OR = 1.3 (95% CI: 0.9 – 2.1).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Using Swedish registry data, Stephansson et al. [25] con-
ducted a logistic regression analysis to assess the influence
of IPI on the subsequent risk of stillbirth and early neona-
tal death, controlling for maternal characteristics and pre-
vious pregnancy outcome (stillbirth, early neonatal death,
pre-term, or small for gestational age). Compared with
IPIs 12–35 months, very short IPIs (0–3 months) in uni-
variate analysis were associated with increased risks of
stillbirth (crude OR = 1.9; 95% CI: 1.3–2.7) and early neo-
natal death (crude OR = 1.8; 1.2–2.8, respectively). How-
ever, after adjusting for maternal characteristics and
previous reproductive history, women with IPIs 0–3
months were not at increased risk of stillbirth (adjusted
OR = 1.3; 95% CI: 0.8–2.1) or early neonatal death
(adjusted OR = 0.9; 95% CI 0.5–1.6). IPIs exceeding 72
months increased women's risk of stillbirth (adjusted OR
= 1.5; 95% CI: 1.1–2.1) and demonstrated a trend toward
increased risk of early neonatal death (adjusted OR = 1.3;
95% CI: 0.9–2.1 [NS]) [LOE: 2+].
In the US, Kallan et al. [26] used a logistic regression
model to examine the magnitude and shape of the IPI
effect on three pregnancy outcomes: pre-term low birth
weight, intrauterine growth retardation with low birth
weight, and fetal loss. Data were analysed from 104 preg-
nancies extracted from the US National Survey of Family
Growth in 1988. Controlling for demographic variables
and reproductive characteristics, short and long IPIs were
associated with increased risk of both fetal loss and intra-
uterine growth retardation with low birth weight [LOE:
2+].
Examining prolonged birth spacing in an urban hospital
in Nigeria, Orgi et al. [27] conducted a case-control study
to determine the reasons for prolonged birth spacing and
Abebe and Yohannis 1996 [28] Ethiopia. Maternity ward at Jimma 
Hospital.
Cross-sectional study. Women (N 
= 415) who delivered during 
September 1992 to March 1993. 
Three trained midwives collected 
the information by use of pre-
tested questionnaire.
Midwives interviewed mothers 
regarding age, marital status, 
income, education, parity, 
contraceptive usage, duration of 
breast feeding, and pregnancy 
outcomes.
Spontaneous abortion: 32.2% vs. 
13.2% in intervals under 12 months vs. 
12–24 month intervals, respectively.
SBR: 3.2% among birth intervals under 
12 months.
Early neonatal death rate (within first 
week of life): 6.9% among birth 
intervals under 12 months.
Pregnancy wastage (abortion, stillbirth 
or neonatal mortality): 42.3% among 
women with birth intervals under 12 
months. The proportion of pregnancy 
wastage declined with an increased 
birth interval.
Kallan 1992 [26] US. Data from the national survey 
of family growth in 1988.
Retrospective study. N = 104 
pregnancies among non-
institutionalised women aged 15–
44.
Assessed the association of short 
and long IPIs on IUGR, LBW and 
fetal loss.
Short and long IPIs increase the risk of 
both intrauterine growth retardation 
low birth weight and fetal loss.
Zimmer 1979 [23] Scotland (Aberdeen).
Observational study.
N = 3098 once married women, 
who had a pregnancy outcome 
during the period 1950 to 1955 for 
a total of 10,825 pregnancies.
Assessed the impact of the spacing 
of pregnancies on outcome.
Women who experience a wastage at 
any given pregnancy number are not 
only more likely to have another 
pregnancy, but they do so over a short 
time interval than those whose last 
pregnancy resulted in a live birth. 
Except for terminations, wastage is 
highest among women who closely 
space their pregnancy.
Kamau and Mati 1988 [122] Kenya (Nairobi). Kenyatta National 
Hospital.
Cross sectional survey.
Women (N = 615) delivered 
during the months of June and July 
1985, who had at least one birth 
interval to report (N = 2407 
pregnancies and 1792 birth 
intervals).
Assessed the impact of birth 
intervals on pregnancy outcome.
SBR and first week death rates: the 
lowest rates (1.9% and 3.2% 
respectively) were observed when the 
preceding birth interval was 25–36 
months. PMR: 5.2% for this interval.
Birth intervals that were 25–36 
months long were associated with the 
most favorable pregnancy outcome. 
Poor pregnancy outcome was 
followed by very short birth intervals.
Table 3: Impact of birth spacing on stillbirth and perinatal mortality (Continued)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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assess its impact on maternal and perinatal outcome com-
pared to shorter birth spacing. Multiparous women (N =
50) with prolonged birth spacing (≥ 6 years) and controls
with shorter birth spacing (2–5 years) were matched for
age, parity and socio-economic status, and their labour
outcome, Apgar scores, operative and vaginal delivery
rates, perinatal and maternal outcome, and reasons for
prolonged birth spacing were compared. There were no
perinatal or maternal deaths in either group, and no sig-
nificant differences in labour experiences or interventions
required [LOE: 2+].
There are other studies that have assessed the impact of
birth intervals, rather than IPIs, on pregnancy outcomes.
Among women (N = 415) delivering at a semi-rural hos-
pital in Ethiopia, Abebe et al. [28] conducted an interview
study to assess determinants and consequences of birth
intervals. In the sample of 415 women with 2009 preg-
nancies, the mean birth interval was 22.1 months; 13.2%
were <12 months. Almost half (42.3%) of these short
birth intervals resulted in miscarriage (32.2%), stillbirth
(3.2%), or neonatal mortality (6.9%). Adverse outcomes
declined with increased birth interval. Unfortunately, this
study assessed intervals between reproductive events
rather than inter-conceptional intervals, which may over-
represent the prevalence of poor outcomes associated
with short IPI [LOE: 3].
Conclusion
Relatively few studies have evaluated the impact of IPI on
stillbirths and perinatal mortality, and all have been
observational (overall Grade C evidence). While most
observational studies suggest that short IPIs are associated
with increased perinatal mortality, few reported stillbirths
as a primary or secondary outcome. In several studies,
after controlling for possible confounding, the association
of IPI with adverse outcome became non-significant, but
it is possible that studies were unable to appropriately
control for confounding given differences between
women with shorter versus longer IPIs. Regardless of
impact on birth outcomes, family planning and options
for desired birth spacing present a key intervention to
improve maternal health and nutrition, birth outcomes
and population health in general.
Reducing indoor air pollution
Background
Half of the world's population relies on the burning of
solid fuels for everyday energy needs. These fuels are typi-
cally burned indoors or in partly enclosed cooking areas
using poorly vented, inefficient stoves. Because cooking is
commonly considered the domain of women, smoke
exposure is typically highest for women of childbearing
age and their young children. Women usually continue
with their cooking duties while pregnant, indirectly
exposing the developing fetus to harm that could result in
stillbirth or neonatal death. Fuel smoke may lead to
impaired fetal growth due to hypoxia and/or oxidative
stress from smoke constituents such as carbon monoxide
and particulates.
Literature-based evidence
Three recent South Asian studies assessed the risk of still-
births associated with indoor air pollution from solid fuel
use (Table 4). In India, Mavalankar et al. [29] evaluated
risk factors in stillbirth cases (N = 451) and normal con-
trols (N = 1465), finding a nonsignificant increase in risk
of stillbirth among those exposed to smoke (OR = 1.5,
95% CI: 1.0–2.1) [LOE 2+]. Another Indian study of pop-
ulation-based data from the second Indian National Fam-
ily Health Survey by Mishra et al. [30] examined the
association between household use of biomass fuels
(wood, dung, and crop residues), tobacco smoke (both
active and passive), and risk of stillbirth. Adjusting for
confounders, the study found that women who cooked
with biomass fuels were significantly more likely to have
experienced a stillbirth than those who cooked with
cleaner fuels (OR = 1.44, 95% CI: 1.04–1.97); and had
double the risk of recurrent stillbirth (RRR = 2.01, 95% CI:
1.11–3.62) [LOE 2++]. In Pakistan, Siddiqui et al. [31]
found a nearly two-fold increased risk of stillbirth among
women exposed to biomass fuel during pregnancy (OR =
1.90, 95% CI: 1.10–3.20) [LOE 2+].
Conclusion
The above studies, while limited in geographic scope and
largely observational, provide uncertain level evidence
linking exposure to indoor air pollution with increased
risk of stillbirth (Grade C evidence). There is a need for
rigorous prospective randomised intervention studies in
relevant contexts to determine whether exposure to bio-
mass fuels is causal for stillbirth, as the existing studies on
the subject are observational and cannot control for a
number of sociodemographic differences between
women who use cleaner versus less clean fuels. There is
also a need to develop and test behavioural and structural
means of minimizing exposure of pregnant women to
indoor air pollution, particularly exposure to biomass
fuels. These interventions could include behaviour
change, communication about the risks of indoor air pol-
lution, construction of improved cooking implements or
increasing availability and lowering the cost of alternative
cooking methods and/or cleaner fuels, one example being
the solar-powered cookers utilized in Kenya, Zimbabwe,
and Nepal, among other countries [32].
Smoking cessation in pregnancy
Background
Smoking is one of few potentially preventable factors
associated with a number of poor pregnancy outcomesBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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including low birth weight (LBW), pre-term birth, still-
birth, and neonatal death. Prevalence studies in the 1990s
show that 20–33% of pregnant women in developed
countries reported smoking [33], and rates have been
increasing in many low- and middle-income countries.
Smoking has been associated with a 50% increased risk of
intrapartum stillbirth compared to non-smokers
(adjusted HR = 1.5; 95% CI: 1.3–1.7). Heavy smoking
(10–19 cigarettes per day) raised the risk of intrapartum
stillbirth by 70% compared to non-smokers (adjusted HR
= 1.7, 95% CI: 1.4–2.0) [34]. The main constituent in
tobacco, nicotine, crosses the placenta with fetal levels
reaching 15% higher than the maternal levels [35]. Nico-
tine causes vasoconstriction of the uterine and possibly
the umbilical artery, and may also have a direct deleteri-
ous effect on the central respiratory control mechanism,
leading to fetal hypoxia-ischemia and ultimately, still-
birth.
Interventions for smoking cessation among pregnant
women mainly employ behavioural and cognitive coun-
selling [36]. Effective behavioural intervention programs
include practical advice in problem solving and skills
training and provision of social support [37]. Other strat-
egies include multi-media education campaigns, tele-
phone quit lines, fiscal incentives, and biomarker
feedback [38]. The American College of Obstetricians and
Gynecologists has proposed a five-step intervention pro-
gram, called the "5 A's" model (ask about use, advise to
quit, assess willingness to quit, assist, and arrange follow-
up) to assist pregnant women quit smoking [39,40].
Women not ready to quit are to be given motivational
intervention via "5 R's" (relevance, risk, rewards, road-
blocks, and repetition) [41].
Pharmacotherapy can also be potentially used for strongly
addicted women [36]. Among pharmacotherapies, nicto-
tine replacement therapy (NRT) during pregnancy has not
been approved by the US Food and Drug Administration,
as its efficacy has not been studied in controlled clinical
trials [36]. Nicotine is considered teratogenic and so the
safety of NRT is questionable. The largest study on coun-
selling and use of a nicotine patch (vs. a placebo patch)
from Denmark, consisting of 250 pregnant women found
no statistically significant difference in smoking cessation
rates between the two groups (28% vs. 25% at 4 weeks
before delivery, respectively) [42]. Tricyclics, bupropion,
and mono-amine oxidase inhibitors are other possible
drugs, but only bupropion appears to be effective [38].
There are two small comparative studies from high-
income countries looking at the safety of bupropion in
pregnancy [43,44], and the larger one [44] found no sta-
tistical differences between bupropion and other compar-
ison groups in risk of malformations or miscarriage. There
Table 4: Impact of indoor air pollution on stillbirth and perinatal mortality
Source Location and Type of Study Intervention/Study Objective Stillbirths/Perinatal 
Outcomes
Observational Studies
Mavalankar et al. 1991 [29] India (Ahmedabad). Urban hospital.
Case-control study of stillbirth cases 
(N = 451), early neonatal death (N = 
160), and healthy controls (N = 
1465).
Used interviews to assess exposure to 
cooking smoke during pregnancy and 
assess odds of stillbirth and early 
neonatal death based on exposure status.
SB: adjusted OR = 1.5 (95% CI: 
1.0–2.1) [NS]
Mishra et al. 2005 [30] India, population-based data.
Analysed data from the Second 
National Family Health Survey 
(1998–99), N = 19189 ever-married 
women at end of reproductive 
career.
Used multivariate analysis to assess 
association of cooking smoke exposure 
with stillbirth risk, controlling for other 
factors. Categorised women by response 
to fuel types used for cooking/heating:
High exposure (wood, dung and 
crops);
Medium exposure (mix of biomass, 
cleaner fuels, coal, etc.); and
Low exposure (liquid propane, 
electricity, kerosene, natural gas).
SB: adjusted OR = 1.44 (95% CI; 
1.04–1.97), biomass vs. cleaner 
fuels.
Recurrent SB: adjusted relative 
risk (RR) = 2.01 (95% CI: 1.11–
3.62), biomass vs. cleaner fuels.
Siddiqui et al. 2005 [31] Pakistan (Sindh province). Rural, 
semi-rural, semi-urban setting.
Prospective cohort study of pregnant 
women (N = 1404) enrolled through 
a maternal child health surveillance 
program.
Compared risk of stillbirth among 
women cooking with biomass (mainly 
wood) in open fire vs. piped natural gas.
SB: crude OR = 2.28 (95% CI: 
1.34–3.90), wood vs. natural gas 
users.
SB: adjusted OR = 1.90 (95% CI: 
1.10–3.20), wood vs. natural gas 
usersBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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are newer therapies like bromocriptine, varenicline and
cytisine, but safety data is limited to animal studies or
non-randomised trials [38]. Nicotine vaccine is another
novel therapy, but has not yet been tested in phase 3 trials
[38].
Smoking cessation efforts targeted towards pregnant
women and others in their households could plausibly
prevent stillbirth and other adverse pregnancy outcomes;
published evidence for impact of smoking cessation is
reviewed below.
Literature-based evidence
Our literature search identified one Cochrane review on
smoking cessation programmes during pregnancy and
two other observational studies (Table 5). The Cochrane
review by Lumley et al. [33] included 64 trials, of which
51 randomised controlled trials (RCTs) (N = 20,931
women) and 6 cluster-RCTs (N>7500 women) provided
data on smoking cessation and perinatal outcomes (Addi-
tional file 1). Smoking cessation programs led to a signif-
icant reduction in smoking in the intervention groups of
the 48 trials which reported this outcome (RR = 0.94, 95%
CI: 0.93–0.95), effectively stopping 6 of every 100 smok-
ers. The same risk reduction was observed in the 36 trials
that validated smoking cessation (RR = 0.94, 95% CI:
0.92–0.95). Smoking cessation interventions effectively
reduced pre-term birth (RR = 0.84, 95% CI: 0.72–0.98)
and LBW (RR = 0.81, 95% CI: 0.70–0.94), and increased
mean birth weight by 33 g (95% CI: 11–55 g). The meta-
analysis found no statistically significant impact of smok-
ing cessation programs on very low birth weight (< 1500
g), stillbirths, or neonatal mortality, but the analyses had
limited power to find a significant difference. The strategy
of combining rewards for smoking cessation with social
support (as in 2 trials), resulted in a significantly greater
smoking reduction than other strategies (RR = 0.77, 95%
CI: 0.72–0.82). There were no statistically significant
reductions in relapse.
Two observational studies explored the impact of phar-
macotherapies on smoking cessation in pregnancy. Chun-
Fai-Chan et al. [43] conducted a drug safety study that
compared bupropion to other anti-depressants and non-
teratogenic smoking cessation aids, and found no statisti-
cally significant differences in stillbirth rate between the
two groups studied. A cohort study by Strandberg-Larsen
2008 [45] using Danish National Birth Cohort data (N =
87,032 singleton pregnancies) assessed the impact of use
of nicotine replacement therapy. The stillbirth rate was 4.2
per 1000 among users of NRT with a crude hazard ratio
(HR) of 0.75 (95% CI: 0.37–1.15) compared with non-
users. This result must be interpreted with caution as the
sample size of NRT users (N = 1927) was small and the
data were not originally collected for this study.
Table 5: Impact of smoking cessation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention/Study objectives Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Lumley et al. 2004 [33] UK, Ireland, USA.
Meta-analysis (Cochrane). 6 RCTs 
included.
To assess the effects of smoking 
cessation programs implemented 
during pregnancy (intervention) vs. 
standard care/no program 
(controls).
SBR: RR = 1.16 [NS] [data from 5 
RCTs; 35/2261 vs. 30/2264 in 
intervention and control groups, 
respectively].
PMR: RR = 1.13 [NS] [data from 3 
RCTs; 41/2149 vs. 36/2186 in 
intervention and control groups, 
respectively].
Observational studies
Chun-Fai-Chan et al. 2005 [43] UK.
Prospective cohort study. N = 
269; N = 136 bupropion treatment 
vs. nonteratogen (N = 133) 
treatment.
To assess the impact of bupropion 
compared with a nonteratogenic 
smoking cessation aid on stillbirth 
rate.
SBR: 1/136 vs. 0/133 in bupropion 
vs. nonteratogen groups, 
respectively [NS].
Strandberg-Larsen et al. 2008 [45] Denmark. Danish National Birth 
Cohort.
Prospective cohort study. N = 87, 
032 singleton pregnancies (N = 
1927 NRT users, 85,105 non-
users)
Compared the impact on stillbirths 
of NRT use during pregnancy 
(exposed) vs. non-users 
(unexposed).
SBR: crude HR: 0.75 (95% CI: 
0.37–1.15) [NS].
[4.2/1000 vs. 5.7/1000 births 
among NRT users vs. non-users, 
respectively].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Conclusion
The single good quality Cochrane review [33] that exam-
ined the impact of smoking cessation programs on still-
births and perinatal mortality provides strong evidence of
reduction in LBW and pre-term birth rates, confirming
that smoking cessation can reverse the adverse effects of
smoking on perinatal outcomes. However, the study sizes
of the component studies were too small to observe any
statistically significant reduction in stillbirth incidence.
Additionally, all evidence for the impact of smoking is
from developed countries; there may be fundamental dif-
ferences in other risk factors between smokers in high-
income vs. low-/middle-income countries that are not yet
known and that could influence the effect. The success
rate of behavioural interventions, even when culturally
appropriate, is very modest in low-/middle-income coun-
tries and intervention studies in this regard are urgently
needed. The data on pharmacotherapy is even further lim-
ited. Our overall evaluation of the evidence for smoking
cessation in relation to stillbirths is Grade C. Smoking ces-
sation clearly benefits both mother and fetus, but there is
a need for appropriate studies to confirm trends toward
reduction in stillbirths and early neonatal deaths. These
may need to be undertaken on available large-scale data
sets.
Reducing smokeless tobacco exposure during pregnancy
Background
Tobacco can be smoked in cigarettes, bidis (thin Indian
cigarettes wrapped in a leaf with a thread), cigars, or pipes,
or alternatively chewed or sniffed. In South Asia, for
example, gutka (crushed betel nut with tobacco and other
ingredients and flavourings), betel quid and mishri (pyro-
lysed and powdered tobacco) are routinely used forms of
smokeless tobacco, often as a dentifrice. While women in
developed countries smoke cigarettes more than they use
smokeless tobacco, use of smokeless tobacco is wide-
spread and increasing among women in many low- and
middle-income countries [46]. Use of smokeless tobacco
has been reported to be as high as 17.1% among pregnant
women in India [47]. While the association of cigarette
smoking with stillbirth incidence has been well studied,
evidence of the impact of smokeless form of tobacco on
stillbirths is more limited because of the lower level of
attention afforded to smokeless tobacco use.
Literature-based evidence
We identified three studies on the smokeless tobacco
exposure among pregnant women and its impact on still-
births or perinatal mortality (Table 6). No intervention
studies were identified that tested reductions of exposure
to smokeless tobacco with reported outcomes on still-
births or perinatal deaths.
A well-conducted cohort study by Gupta and Subramoney
[47] in Mumbai, India, (N = 1110 women) reported
higher stillbirth rates among tobacco users compared to
non-users [8.9% (18/202) vs. 3.1% [28/908] respectively;
adj. HR = 2.6, 95% CI: 1.4–4.8). Results were further strat-
ified according to the type of tobacco used; the use of
mishri had a statistically significant 2.5 times higher risk,
while gutka had a significant 5.5 fold greater risk com-
pared to controls. There was a strong dose-related impact
and the risk was highest early in gestation [LOE 2+].
Two hospital-based studies from India explored the use of
smokeless tobacco among pregnant women; one cross-
sectional study (N = 1388 singleton births) reported a 3-
fold increased risk of stillbirth among tobacco chewers
compared to controls [48]. The other study, a case-control
design, reported an increased risk of perinatal death (RR =
1.5, 95% CI: 1.3–1.7) [49].
Table 6: Impact of smokeless tobacco on stillbirths and perinatal mortality
Source Location, Type of Study Intervention Stillbirths/Perinatal Outcomes
Observational studies
Gupta and Subramoney 2006 [47] India. Population-based.
Cohort study. N = 1110 pregnant 
women.
Compared the impact on stillbirths 
of women using smokeless tobacco 
(exposed) vs. non-users 
(unexposed).
SBR: adj. HR = 2.6 (95% CI: 1.4 – 
4.8).
[18/202 (8.9%) vs. 28/908 (3.1%) 
among exposed and unexposed 
groups, respectively].
Krishna 1978 [48] India (Pune). Hospital-based.
Cross-sectional study. N = 1388 
singleton births.
Analyzed the impact on stillbirths of 
pregnant women who were 
tobacco chewers vs. non-users.
SBR: 3 times higher risk among 
tobacco users vs. controls.
Shah et al. 2000 [49] India. Multicentre, hospital-based.
Case-control study.
Compared the impact on perinatal 
mortality of women using tobacco 
vs. non-users.
PMR: 1.5 times higher risk (95% CI: 
1.3 – 1.7).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Conclusion
Based on the above studies, smokeless tobacco use
emerges as a clear risk factor for stillbirth; its use is associ-
ated with an increased risk of stillbirth similar in magni-
tude to that associated with maternal cigarette smoking.
Smokeless tobacco use has also been linked to other
adverse pregnancy outcomes including growth restriction,
pre-term delivery, and changes in placental morphology,
which may mediate the higher stillbirth risk observed; nic-
otine exposure alone may also lead to fetal hypoxia-
ischaemia. Studies on smokeless tobacco use and its phys-
iological effects in pregnancy have been mainly limited to
South Asia; more studies are needed from other countries
where its use may be prevalent. Additionally, there is a
need for studies that design and test cessation pro-
grammes for smokeless tobacco use, to determine
whether these programmes can effectively reduce smoke-
less tobacco use and thus impact perinatal outcomes
including stillbirth incidence.
Antenatal care (ANC) packages
Background
The main function of ANC is to prevent or identify and
treat conditions that may threaten the health of the fetus,
newborn and/or the mother and to help a woman
approach pregnancy and birth positively. In practice, ANC
packages comprise a wide constellation of interventions
that a pregnant woman receives from organised health
care services, often provided in clinics or through outreach
services. Although the World Health Organization
(WHO) has proposed standardised content and visitation
schedules, in different countries and different settings
[50], the component interventions that comprise an ANC
package may vary widely.
In low- and middle-income country communities, where
it may be difficult for women to access facility-based care
and where births often occur at home, ANC may be pro-
vided through primary health care or outreach clinics
using various nursing cadres and physicians, and occa-
sionally by female community health workers who make
household visits. At a basic level, ANC components may
include taking the woman's medical and obstetric history
and general health assessment, measuring weight gain
and fundal height, administration of two doses of tetanus
toxoid immunisation, counseling on birth preparedness
and postnatal care, and distributing vitamin supplements
(especially iron and folate). In malarious areas, ANC may
also include malaria chemoprophylaxis, intermittent pre-
ventive treatment, and bednet distribution. Where techni-
cally and economically feasible, ANC may also include
screening for maternal infections and conditions such as
pregnancy-induced hypertension, gestational diabetes,
and STDs including HIV and syphilis.
This variability of ANC based on local population charac-
teristics and capacity of the health system complicates
measurement, because the particular interventions deliv-
ered – and potential synergies between these interven-
tions – may have an impact on stillbirths as well as
neonatal outcomes. Other variables that may have an
impact on stillbirth rates include the quality of care as well
as the frequency and timing of its delivery. Relatively few
studies of ANC have specifically considered stillbirth as an
outcome.
Literature-based evidence
The literature review identified 3 Cochrane reviews com-
prised of 14 RCTs; one large WHO meta-analysis; and 24
other studies (Table 7, 8, 9, 10), evaluating many different
facets of ANC, including comparisons of the timing and
frequency of ANC visits, the type of provider, and the
impact of ANC packages and specific component inter-
ventions on perinatal outcomes.
Impact of ANC on mortality
Several studies from high-, middle- and low-income
countries have found significant impact of facility-based
ANC on perinatal outcomes. Some studies examined the
impact of not having ANC on perinatal outcomes. South-
wick et al [51] found that among women with inade-
quately treated current syphilis, those without ANC were
more likely to have a stillborn infant than those with ANC
(OR = 9.5; 95% CI: 4.0–23.5) [LOE: 2-]. In India, Shah et
al. [52] found stillbirth rates of 35.1/1000 vs. 20.8/1000
among women without ANC vs women with ANC, respec-
tively (P < 0.05) [LOE: 2+]. Using German registry data,
Gunter et al. [53] retrospectively compared pregnancies
without any ANC (N = 2208) with pregnancies with
standard ANC (N = 163,143), and found a six-fold
increased risk of stillbirth among women without prena-
tal care (OR = 6.1, 95% CI: 4.7–7.8, P < 0.01), though the
study design was unable to adjust for confounding [LOE:
2-]. Fawcus et al. [54] used a case-control study to com-
pare fetal outcomes at Harare Maternity Hospital, Zimba-
bwe among recently delivered mothers who had (N =
196) and had not (N = 195) booked for ANC. Infants
born to unbooked mothers, who were significantly more
likely to be young, primiparous, single, poor, under-edu-
cated, and have an unwanted pregnancy, had significantly
higher perinatal mortality [LOE: 2-].
Three studies evaluating ANC packages identified causes
of perinatal mortality and assessed the association of
access to care with perinatal mortality. In Zimbabwean
villages, Nilses et al [55] interviewed women (N = 1213)
about their use of maternity care and complications dur-
ing pregnancy/labour during their most recent pregnancy.
85% of deliveries occurred in facilities, and the perinatal
mortality rate (PMR) (889 women had completed 3601BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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pregnancies) was 23/1000 births. Overall rates of compli-
cations and perinatal deaths were comparatively low, pos-
sibly because almost 94% of women received ANC. This
number was significantly greater than regional averages,
although no cause-effect relationship between ANC and
mortality risk can be inferred from this study [LOE: 2-]. In
four villages in rural Haryana, India, an observational
study by Kumar et al. [56] compared the impact of differ-
ential access to antenatal and delivery care on perinatal
outcomes. Availability of modern maternity facilities was
inversely correlated with delivery by a traditional birth
attendant (TBA). Availability of modern maternity serv-
ices at a primary health centre significantly influenced
health-seeking behaviour and pregnancy outcome, as
there was no significant difference in PMR between vil-
lages with a sub-centre as opposed to no health centre
(87.4/1000 vs. 76/1000, respectively), but the rate in the
village with the primary health centre was significantly
lower (38.9/1000, P < 0.01) [LOE: 2-].
Frequency of ANC visits
The number of visits and type of provider may impact
perinatal outcomes. A systematic review of 7 RCTs (N =
57,418 women) conducted by WHO [57] (Additional file
2) evaluated the effectiveness of different models of ANC
and found that reduced numbers of visits were as effective
as standard models of ANC in terms of impact on LBW
and PMR. Five randomised trials (two individual-ran-
Table 7: Systematic reviews on the impact of ANC on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Hodnett and Fredericks. 2003 [70] France, Australia, USA, South 
Africa, England, Argentina, Brazil, 
Cuba, and Mexico.
Meta-analysis (Cochrane). 11 
randomised controlled trials 
(RCTs) (N = 9507 women) 
included.
Compared additional support 
during pregnancies at risk of low 
birth weight by either a 
professional (social worker, 
midwife, or nurse) or specially 
trained layperson, to routine care. 
Additional support included 
emotional support, information/
advice, and physical help.
PMR: RR = 1.15 (95% CI: 0.89–
1.51) [NS]a
Gagnon and Sandall.
2007 [71]
Canada, USA.
Meta-analysis (Cochrane). 1 RCT 
(N = 1280 women) included (N = 
641 intervention group, N = 634 
controls).
As part of a strategy to define 
predisposing, enabling, and 
reinforcing factors for deciding to 
attempt a vaginal birth after 
Caesarean (VBAC), the study 
compared pregnancy outcomes 
among an intervention group given 
individualised prenatal education 
and support by a trained research 
nurse and a resource person with 
personal experience of a VBAC to 
a group of controls given a 
pamphlet highlighting the benefits 
of a VBAC.
PMR: RR = 0.50 (95% CI: 0.09–
2.69) [NS]
[2/643 vs. 4/637 in intervention 
group vs. controls, respectively]
Villar and Khan-Neelofur 2001 
[65]
Scotland, UK.
Meta-analysis (Cochrane). 2 RCTs 
(N = 2890 low-risk women) 
included.
To assess the effects of ANC 
programs for low-risk women, 
particularly whether care provided 
by a midwife/general practitioner 
was as effective as obstetrician/
gynecologist-led shared care.
PMR: Odds ratio (OR) = 0.59 (95% 
CI: 0.28–1.26) [NS]
Carroli and Villar 2001 [57] Multiple countries.
Meta-analysis (World Health 
Organization, WHO). 7 RCTs (N 
= 57,418 women) included (N = 
30,799 in intervention groups, N = 
26,619 in standard ANC groups). 5 
RCTs reported perinatal mortality 
(N = 54,005 women).
To test the impact of a reduced 
number of ANC visits, with or 
without goal-oriented 
components, on perinatal 
mortality against standard ANC.
PMR: OR = 1.06 (95% CI: 0.82–
1.36) [NS]
aNS = Non-significantBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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domised and three cluster-randomised) [58-62] in the
WHO meta-analysis reported perinatal mortality, but
found no statistically significant differences between
intervention and control groups (OR = 1.06, 95% CI:
0.82–1.36) [LOE: 1++]. A more recent RCT from rural
Zimbabwe [63] that tested five focused ANC visits with
standard ANC found non-significant differences in still-
birth and perinatal mortality rates [LOE: 1+]. Data corre-
lations suggest that the impact of ANC may be of
incremental benefit, but the data are mixed. Using coun-
try comparisons, Goldenberg et al. [6] found that for each
1% increase in the percentage of women with ≥ 4 antena-
tal visits, the intrapartum stillbirth rate decreased by a
modest 0.16 per 1,000 births (P < 0.0001) [LOE: 3], in
line with findings from a similar analysis by McClure et al.
[64][LOE: 3]. A study by McDuffie et al. [62] in Denver,
USA, clearly indicated that birth outcomes and perinatal
mortality were comparable in pregnant women receiving
4 ANC visits versus a more frequent visitation schedule
[LOE: 1++]. However, other trials from developed coun-
tries suggest that women may feel less satisfied with the
reduced number of visits or feel that their expectations
with care are not fulfilled [58].
Type of providers
Whether ANC can be more effectively provided by practi-
tioners other than doctors has important cost and cover-
age implications. ANC can be managed effectively by
general practitioners or midwives, rather than obstetri-
cians, without negatively affecting maternal and birth out-
comes [65] (Additional file 3) [LOE: 1+]. Ratten and
McDonald [66] monitored perinatal outcomes for low-
risk pregnancies at a public hospital-based ANC pro-
gramme in Australia where ANC was provided by hospital
doctors in cooperation with local practitioners. Patients
who completed the programme (N = 780) had a signifi-
cantly lower PMR than the hospital-wide population,
which included women cared for only by doctors (6.4/
Table 8: Other intervention studies on the effect of ANC on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Intervention studies
Lovell et al. 1987 [123] UK.
RCT. N = 246 women.
Compared an intervention group of women 
who were allowed to carry their full set of 
antenatal records until childbirth to a control 
group who carried a 'co-op card,' with their 
maternity notes retained by the hospital.
PM: RR = 1.04 (95% CI: 0.15–
7.24) [NS]
[2/104 vs 2/108 in intervention 
group vs control group, 
respectively]
Majoko et al. 2007 [63] Zimbabwe, rural ANC/primary 
care clinics.
Cluster (clinic-randomised) RCT. 
N = 13,517 low-risk pregnant 
women (N = 6897 intervention 
group, N = 6620 controls).
Compared pregnancy outcomes among 
women who completed a focused 5-visit ANC 
program with controls given standard ANC 
(13 visits, every 4 weeks from booking until 28 
wks, every 2 wks between 28 and 36 wks and 
weekly after 36 wks until childbirth). Mean 
visits achieved: 4 for intervention group, 4 for 
control group.
SB: OR = 0.89 (95% CI: 0.62–
1.27) [NS]
[12.0/1000 vs 13.5/1000 in 
focused ANC vs standard ANC 
groups, respectively]
PMR: OR = 1.11 (95% CI: 0.89–
1.39) [NS] [28/1000 vs. 25.2/
1000 in focused ANC vs 
standard ANC groups, 
respectively]
O'Rourke 1998 [78]. Bolivia (Inquisivi Province). Rural 
community-based setting.
Before-after study. N = 409 
women.
Evaluated the impact of an intervention that 
initiated and strengthened women's 
organisations, developed women's skills in 
problem identification and prioritisation, and 
trained community members in safe birthing 
techniques in terms of utilisation of ANC. 
Outcome measures included breastfeeding 
rates, participation in women's organisations, 
and perinatal mortality.
PM: 62.4% reduction (P < 0.001)
[4.4% after vs. 11.7% before the 
program]
Wilkinson et al. 1991 [72] South Africa (Lebowa). Rural 
hospital (Jane Furse Hospital).
Before-after study. N = 640 
women assessed at baseline, N = 
2193 women assessed after 
intervention.
Employed perinatal audit to identify causes of 
perinatal death, then implemented targeted 
intervention strategies to reduce the number 
of preventable perinatal deaths.
PM: 31.7% reduction (χ2 = 3.871 
df, P < 0.05) [60/1000 (38/640) 
before vs 41/1000 (90/2193) 
after]
Reduction in potentially 
avoidable deaths: (χ2 = 4.501 df, P 
< 0.05)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
Page 15 of 35
(page number not for citation purposes)
Table 9: Observational studies studying the impact of ANC on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Observational studies
Bhardwaj et al. 1995 [77] India (Uttar Pradesh). Rural 
setting.
Longitudinal study. 4 rural villages, 
1987–88. N = 212 women.
Within the context of a home-based 
ANC program, assessed how a 
composite measure of maternal care 
receptivity (MCR), a weighted score 
based on initiation of ANC, frequency 
of home-based visits accepted, number 
of doses of tetanus toxoid, and place of 
and type of attendant at delivery, 
impacted perinatal outcomes. Subjects' 
MCR was graded as poor (N = 36, 
17%), moderate (N = 161, 75.9%), or 
high (N = 15, 7.1%).
SB rate: 30/1000, 25/1000, 0/1000 in 
poor, moderate, and high MCR 
groups, respectively.
PM rate: 90.9/1000, 86.9/1000, and 
0/1000 in poor, moderate, and high 
MCR groups, respectively
Neonatal mortality rate (NMR): 
93.8/1000, 63.7/1000, and 0/1000 in 
poor, moderate, and high MCR 
groups, respectively.
High MCR group significantly 
different from low/moderate MCR 
groups (Z = 5.46, P < 0.0001).
Dyal Chand et al. 1989 [73] India (Aurangabad, Maharashtra). 
Rural setting.
Community-based surveillance 
and monitoring, 1979–80 and 
1987–88. 50 rural villages. N = 
unspecified.
Evaluated the impact of maternal health 
services on perinatal and neonatal 
mortality, delivered by TBAs, 
community health volunteers, and 
female workers.
Fetal deaths: 27% reduction [NS]
[1979–80 = 15.6/1000; 1987–88 = 
11.4/1000]
Fauveau et al. 1990 [75] Bangladesh (Matlab).
Prospective cohort study. 1979–
1982. N = 13818 cases, N = 
16781 controls.
Assessed the impact of the Intensive 
Family Planning and Health Services 
Programme on pregnancy outcomes, 
compared to controls given routine 
ANC.
PM rate: 21% reduction among 
intervention group over 8 years of 
study (P < 0.001)
[82/1000 at start vs. 65/1000 8 years 
later]
Fawcus et al. 1992 [54] Zimbabwe (Harare). Hospitals 
setting.
Case control study. N = 195 
unbooked recently delivered 
mothers (cases), N = 196 booked 
mothers (controls).
Compared the impact on pregnancy 
outcomes of having had or not had 
ANC (booked vs. unbooked mothers).
PMR: 72% reduction in children of 
booked vs. unbooked mothers (P < 
0.001)
[35.9/1000 vs 129.7/1000 in booked 
vs. unbooked mothers, respectively].
Booked mothers also had lower 
MMR.
Goldenberg et al. 2007 [6] 51 countries (developed and 
developing).
Retrospective analysis of data 
from WHO and other sources.
Assessed how the number of antenatal 
visits impacted intrapartum stillbirth 
rates.
SBR (intrapartum): For each 1% 
increase in the percentage of women 
with at least 4 antenatal visits, the 
intrapartum stillbirth rate decreased 
by 0.16 per 1,000 births (P < 
0.0001).
Gunter et al. 2007 [53] Germany.
Retrospective study. Data from 
the Perinatal Registry of Lower 
Saxony.
Compared odds of stillbirth for 
pregnancies without any ANC vs. 
pregnancies with ANC.
SBR: OR = 6.089 (95% CI: 4.7–7.8, P 
< 0.01) for pregnancies without vs. 
pregnancies with ANC.
Kumar et al. 1997 [56] India (Ambala, Harayana). Rural 
Rajpur Rani.
Cross-sectional survey. 4 rural 
villages with varying health 
services. N = 600 married women 
age 15–45.
Assessed how health care availability 
impacted utilisation of maternity care 
and pregnancy outcome, comparing 2 
villages without any health centre (HC) 
to 1 village with a sub-centre (SC) and 
another village with a primary health 
centre (PHC).
PMR: 76.0/1000 in villages without 
HC
87.4/1000 in SC village
38.9/1000 in PHC village
Difference between village with PHC 
and all other villages was statistically 
significant (P < 0.01).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Kwast et al. 1995 [79] Guatemala and Bolivia (also 
Indonesia and Nigeria, but these 
projects did not involve ANC)
Before-after studies measured by 
cross-sectional survey to evaluate 
MotherCare demonstration 
projects.
In Guatemala, the Quetzaltenango 
maternal and neonatal health project 
involved training 400 TBAs (to manage 
a population of 150,000), improving 
TBA-to-hospital referral services and 
posting a neonatologist. In Bolivia, the 
Warmi project engaged women's 
groups in problem prioritisation and 
action to reduce neonatal health, 
including improved training for 
traditional birth attendants and 
education for mothers during 
pregnancy. ANC attendance increased 
from 45 to 77% over course of project.
PMR:
Guatemala: 47% reduction in PMR 
among referred women in 
intervention area after intervention 
implementation (P = 0.003)
[22.2% before vs. 11.8% after]
Bolivia: 64% overall reduction in PMR
[105/1000 before vs. 38/1000 after]
Maternal deaths declined from 11 to 
7 in the Bolivian study population 
(sample too small to calculate MMR).
McCaw-Binns et al. 1994 [76] Jamaica.
Retrospective cohort study. 
Pregnant women included in the 
Jamaican Perinatal Mortality 
Survey, including all deliveries 
Sept-Oct 1986 and all perinatal 
deaths (N = 9919).
Assessed the timing of ANC initiation 
and its association with pregnancy 
outcomes, particularly perinatal 
mortality. Those who initiated ANC 
during the 2nd trimester served as the 
reference group.
PMR:
Began in 1st trimester: OR = 0.67 
(95% CI: 0.54–0.83)
Began in 2nd trimester: OR = 1.00 
[reference]
Began > 29 wks: OR = 1.04 (95% CI: 
0.82–1.31) [NS]
Protective effect of early initiation of 
ANC (χ2 = 14.5, P < 0.001)
McClure et al. 2007 [64] 188 countries (low, middle, and 
high-income).
Retrospective regression analysis 
using WHO data.
Assessed the association of number of 
ANC visits with stillbirth incidence.
SBR: Regression analysis results: an 
increase of 1% of women with ≥ 4 
antenatal visits decreased SB by 
0.22/1000 (P < 0.0001) [all 
countries].
0.18/1000 (P = 0.0002) [low- and 
middle-income countries] 0.04/1000 
(P = 0.5789) [high-income countries]
McCord et al. 2001 [124] India (Ahmedagar & Pune 
districts).
Prospective cohort study. 
Pregnant women (N = 2905) in 
25 villages in Ahmedagar district; 
controls drawn from neighboring 
Pune district.
A comprehensive rural health project 
was set up in a rural community with 
predominantly home births and limited 
access to emergency obstetric care. 
64% of perinatal deaths were infants 
delivered at home.
SBR: 4% reduction [no significance 
data], [18.9/1000 vs 19.6/1000 in 
intervention group vs. controls, 
respectively]
PMR: 20% reduction [no significance 
data], [36/1000 vs 45.2/1000 in 
intervention group vs. controls, 
respectively]
MMR: 28% reduction [no significance 
data]. [70/100,000 vs 97/100,000 in 
intervention group vs. controls, 
respectively]
Nilses et al. 2002 [55] Zimbabwe (Gutu, Masvingo 
Province). Rural setting.
Cross-sectional survey in 12 
villages. N = 1213 women aged 
15–44 years (N = 889 women had 
completed 3601 pregnancies).
Assessed self-reported reproductive 
outcome and utilisation of care to 
identify associations with perinatal 
outcomes.
PMR: 23/1000 among women who 
used ANC services vs. 40/1000 
national figures [NS]
ENMR: 8.4/1000.
Panaretto et al. 2007 [74] Australia (Queensland). 
Community-based study.
Before-after design. N = 865 (N = 
781 after, N = 84 before).
Evaluated the impact of the Mums and 
Babies program, a community-based 
quality improvement intervention 
providing collaborative ANC care, in a 
cohort of women attending Townsville 
Aboriginal and Islanders Health Service 
(MB group), compared with a historical 
control group (PreMB group).
PMR: 77% reduction (P = 0.014)
[14/1000 vs. 60/1000 in MB group vs 
PreMB group, respectively]
Table 9: Observational studies studying the impact of ANC on stillbirth and perinatal mortality (Continued)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Salinas 1997 [82] Mexico. Hospital records.
Retrospective analysis using 
hospital records maintained by 
the National Institute for 
Perinatology, Mexico City, 
comparing avoidable perinatal 
death cases (N = 181) to non-
avoidable deaths that served as 
controls (N = 341).
Assessed the relationship of quality of 
care to perinatal mortality by 
comparing avoidable perinatal deaths 
with non-avoidable perinatal deaths.
PMR: 24.8/1000 overall, possible 
35% reduction if all avoidable 
perinatal deaths were prevented.
16% of the deaths presented 
structural and 31.2% process 
deficiencies; both predominated 
among avoidable perinatal deaths 
(35.4% vs 5.3%, P < 0.000; and 79.3% 
vs 5.9%, P < 0.000, respectively). 
Structural deficiencies increased risk 
avoidable perinatal death (OR = 11; 
95% CI: 4.1–26.9. P < 0.001), as did 
process deficiencies (OR = 88, 95% 
CI: 37.2–204.5, P < 0.001).
Shah et al. 1984 [52] India.
Prospective community-based 
study. N = 3151 women with live 
births, N = 90 women with 
stillbirths.
Compared the impact on perinatal 
outcomes between women who had 
had ANC vs. women who had had no 
ANC.
SBR: 35.1/1000 vs 20.8/1000 among 
women without ANC vs women 
with ANC, respectively. (P < 0.05)
67% (60/90) of mothers with 
stillbirths had no ANC, compared 
with 54% (1707/3151) women who 
had live births.
Southwick et al. 2007 [51] Russia. Multisite study.
Prospective cohort study. Studied 
women with syphilis (N = 1071).
Compared the impact on perinatal 
outcomes between women who had 
had ANC vs. women who had had no 
ANC.
SBR: OR = 9.5 (95% CI: 4.0–23.5) 
among women with inadequately 
treated current syphilis who had no 
ANC vs those who had ANC.
[25% of those with no ANC had a 
stillbirth, vs. 3% of those with ANC].
aNS = Non-significant
Table 9: Observational studies studying the impact of ANC on stillbirth and perinatal mortality (Continued)
1000 vs. 20.5/1000) [LOE: 2-]. In Australia, Homer et al.
[67] tested a new community-based model of continuity
of care provided by midwives and obstetricians together
by randomizing women to community-based care or
standard hospital care, and found no significant differ-
ences in perinatal outcomes [LOE: 1+].
Additional care pilot programs
The components of ANC packages may be crucial to their
effectiveness, but studies rarely test individual compo-
nents and often fail to specify all components of ANC
when reporting results. A number of studies examined the
impact on perinatal outcomes of enrollment in special
pilot ANC programs providing additional care. Sokol et
al. [68] evaluated the effectiveness of ANC provided under
the Title V Maternity and Infant Care Project at Cleveland
Metropolitan General Hospital; specific component inter-
ventions were not specified. Despite the similar social and
antepartum/intrapartum risk of those who participated in
the project and those who did not, the project patients
experienced 60% less perinatal mortality than the control
group (P < .0001), possibly due to decreased risk of pre-
term delivery [LOE: 2++]. Siegel et al. [69] assessed the
impact of a rural regional perinatal care program in North
Carolina, USA, using a quasi-experimental, controlled,
population-based design to identify high-risk pregnancies
during antenatal visits and ensure access (including trans-
port) to higher-level care for complications. They
observed declines in fetal, neonatal, and birth-weight-spe-
cific mortality rates in both pilot and control regions,
especially for 1501–2500 g infants, though these changes
were not statistically significant between regions [LOE: 
2-].
Hodnett et al. [70] conducted a meta-analysis of interven-
tion studies [N = 11 trials, N = 9507 women] that offered
additional support to at-risk pregnancies by either a pro-
fessional (social worker, midwife, or nurse) or specially
trained lay person, and found no significant evidence that
these interventions were any more effective than routine
ANC (RR = 1.15, 95% CI: 0.89–1.51) [LOE: 1++] (Addi-
tional file 4). A second Cochrane review by Gagnon et al.
[71] (Additional file 5) included just one eligible study in
which a prenatal education and support program was
associated with a large difference in perinatal deaths,
though the finding was not statistically significant (RR =
0.50, 95% CI: 0.09–2.69) [LOE: 1+].
A number of promising interventions focused on upgrad-
ing or improving health systems in rural areas among
poor populations and brought about documented
declines in PMR. In rural township clinics and hospitals in
South Africa, Wilkinson [72] found that structural and
functional changes in the maternity services throughoutBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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the district, using standard protocols for care, and con-
ducting in-service training, effectively and rapidly reduced
perinatal mortality by one-third [LOE: 3]. In rural Mahar-
ashtra, India, Dyal Chand et al. [73] evaluated a maternal
care program delivered by community-based workers and
reported a non-significant 27% reduction in fetal deaths
[LOE: 3]. In Australia, Panaretto et al. [74] evaluated the
Mums and Babies program, which targeted poorer Aus-
tralian Aborigines and Islanders, finding that this commu-
nity-based quality improvement intervention that
provided shared ANC was associated with a 77% reduc-
tion (P = 0.014) in PMR [LOE: 2-]. Fauveau et al. [75]
monitored perinatal deaths from 1979–1986 in rural
Bangladesh as an intensive maternal and child health and
family planning services programme was scaled up. The
perinatal mortality rate declined from 82 to 65 per 1000
(though only statistically significant during the second
half of the study). Because neonatal tetanus was the sec-
ond most common cause of neonatal death, the research-
ers credited tetanus toxoid delivered through ANC as
having the greater share of impact on reducing the perina-
tal mortality in the study area [LOE: 2+]. McCaw-Binns et
al. [76] assessed differences in antenatal and intrapartum
care in singleton pregnancies (N = 9919) delivered in
Jamaica in which the infant survived the early neonatal
period, compared to a group of singleton perinatal deaths
(N = 1847) occurring in a one-year period, classified
according to the Wigglesworth schema. Logistic regression
revealed that maternal iron supplementation appeared to
lower the risk of perinatal death, particularly antepartum
fetal death, and early commencement of ANC in the first
trimester was associated with reduced risk of all perinatal
deaths, but especially intrapartum asphyxia, presumably
due to early detection and treatment of anaemia and syph-
ilis. [LOE: 2+].
Improving maternal access to and utilisation of ANC
At the community level, other variables that impact the
Table 10: Studies of facility based ANC in high-income countries and effect on stillbirths
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Intervention/observational studies of facility based ANC in developed countries
Homer et al. 2001 [67] Australia (Sydney). Hospital-based 
study.
RCT. N = 1089 (N = 550 intervention 
group, N = 539 controls).
Compared the impact of a community-
based model of continuity of care 
employing midwives and obstetricians to 
standard hospital-based care. Women 
were randomised prior to ANC 
booking.
SBR: 7.3/1000 (4/550) vs. 3.7/1000 (2/
539) in intervention vs. control 
groups, respectively [No statistical 
significance data].
Ratten 1992 [66] Australia (Melbourne). Tertiary 
referral hospital.
Prospective cohort study at The Royal 
Women's Hospital. N = 780 low-risk 
pregnant women in shared care 
(intervention group), N = 15436 
hospital patients (control group).
Compared pregnancy outcomes among 
participants in a public hospital based 
shared ANC program to those of 
hospital patients who received standard 
care.
SBR: 5.1/1000 vs 12.5/1000 in 
intervention group (those who 
completed the ANC program) vs. 
controls, respectively. No statistical 
significance data.
PMR: 6.4/1000 vs 20.5/1000 in 
intervention group (those who 
completed the ANC program) vs. 
controls, respectively. No statistical 
significance data.
Siegel et al. 1985 [69] USA (North Carolina). Rural 
community.
Quasi-experimental, controlled, 
before-after pilot study. Pregnant 
women (N = 3384 intervention, N = 
2996 controls).
Assessed the impact of a rural regional 
perinatal care program
Fetal deaths: [NS]
NMR: [NS]
Note: Fetal deaths, NMR, and birth-
weight specific mortality rates 
declined in both pilot and control 
regions, for both races, and especially 
for 1501–2500 g infants.
Sokol et al 1980 [68] USA (Cleveland, Ohio). Hospital-
based study.
Case-control study. N = 5416 women.
Compared pregnancy outcomes among 
women enrolled in a multidisciplinary 
maternal and infant care project (cases) 
with women who received standard 
ANC/infant care (controls).
SBR: 57% reduction (P < 0.003)
[6.29/1000 vs 14.77/1000 in 
intervention vs. control groups, 
respectively]
PMR: 60% reduction (P < 0.0001)
[14.97/1000 vs 38.39/1000 in 
intervention vs. control groups, 
respectively]
aNS = Non-significantBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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effectiveness of ANC include time of enrollment in ANC
and frequency of visits, both of which are largely depend-
ent on maternal factors, especially social. Bhardwaj et al.
[77] evaluated a home-based ANC program in rural India,
rating pregnant participants (N = 212) for "Maternal Care
Receptivity" (MCR). The study, which was observational
rather than interventional, found that women with high
MCR experienced no perinatal deaths, compared to PMRs
of 90.9/1000 and 86.9/1000 in low- and moderate-MCR
women, respectively (Z = 5.46, P < 0.0001). Low MCR was
attributed to lack of knowledge, illiteracy, poverty, and
deeply rooted confidence in TBAs [LOE: 2-]. O'Rourke et
al. [78] measured the impact of a community participa-
tory intervention in rural Bolivia that trained highly moti-
vated women's groups to identify and solve their own
perinatal problems in an area with limited access to mod-
ern obstetric facilities. Rates of ANC went up, and PMR
decreased from 117/1,000 to 43.8/1,000 births over the
course of the program [LOE: 2-]. A MotherCare Project by
Kwast et al. [79] was conducted in Bolivia, Guatemala,
Indonesia, Uganda, and Nigeria and strengthened mater-
nal and family planning programs in rural and urban set-
tings through policy reform, service improvement, and
behaviour change. Perinatal mortality declined in multi-
ple countries over the project period; the decline was
attributed to behaviour change communications aimed to
increase danger sign recognition and ANC attendance
(Bolivia) and hospital staff training to facilitate antenatal
and obstetric referrals by TBAs (Guatemala) [LOE: 3].
Conclusion
The effectiveness of ANC for a host of maternal and new-
born outcomes has been reviewed elsewhere [80,81].
While it is recognised that effective and appropriate ANC
safeguards maternal health and promotes positive preg-
nancy outcomes and the overall quality of the evidence is
relatively good (Grade B), the evidence that it makes a
specific impact on stillbirth outcomes remains weak. This
may also be related to the fact that relatively few large-
scale studies have evaluated stillbirth outcomes, and most
of the studies that identify significant impact of an inter-
vention appear to be affected by selection bias, where
women who received ANC likely differed from women
who did not receive ANC. Many studies were not adjusted
for potential confounders, and many confounders cannot
be adequately controlled for in vastly different study arms.
Many of the studies reviewed, moreover, did not specify
component interventions that made up the ANC pack-
ages. Assessment of the impact of ANC on stillbirth inci-
dence requires well-designed clinical trials for each
component intervention, which have not been per-
formed, nor may be feasible given the work undertaken
with the WHO collaborative studies.
Routine ANC differs greatly from country to country and
services offered generally do not follow evidence-based
criteria for improving maternal or neonatal outcomes,
much less prevention of fetal deaths. Issues of delays in
seeking and accessing care, and poor quality or availabil-
ity of care, remain unaddressed in many ANC and obstet-
ric care programs, yet these issues are key to preventing
maternal and perinatal deaths. In reviewing clinical data
from Mexico, Salinas et al. [82] postulated that 35% of all
perinatal deaths could have been prevented if structural
(e.g., unavailable or poorly maintained equipment,
absent or insufficient health workers) and process defi-
ciencies (e.g., incorrect diagnoses or poorly performed
procedures), had been addressed (P < 0.0001).
Based on the results of the WHO ANC randomised trial
[59] supported by other studies, models of ANC with a
reduced number of antenatal visits can be introduced – in
high-, middle-, and low-income countries – into clinical
practice without any risk of adverse consequences to the
woman or the fetus, provided those visits are appropri-
ately focused on effective interventions and quality of
implementation is ensured.
Nutritional support during pregnancy
Peri-conceptional folic acid supplementation
Background
Women taking folic acid supplementation peri-concep-
tionally – before pregnancy and during the first two
months of pregnancy – are less likely to give birth to
babies with neural tube defects (NTDs), which account for
a small proportion of stillbirths. The precise mechanism
by which folic acid is protective is unclear. Bjorkland et al.
[83] hypothesised that folic acid provides the methyl
group used for post-translational methylation of arginine
and histidine in the regulatory domains of the cytoskele-
ton, which is required for neural tissue differentiation.
Literature-based evidence
The literature search identified 3 Cochrane reviews assess-
ing 8 RCTs; and 1 other relevant intervention and obser-
vational study (Table 11). Only one Cochrane review by
Lumley et al. [84] specifically assessed the impact of peri-
conceptual folic acid on pregnancy outcomes (Additional
file 6). This meta-analysis reported a non-significant 22%
reduction in stillbirth rate (SBR) (RR = 0.78, 95% CI:
0.34–1.78), but did find a significantly reduced preva-
lence of NTDs (RR = 0.28; 95% CI: 0.13–0.58), including
NTDs among women with no prior NTD (RR = 0.07, 95%
CI: 0.00–1.33) as well as women with prior NTDs (RR =
0.31, 95% CI: 0.14–0.66) [LOE: 1+]. The largest and
strongest RCT in the Lumley meta-analysis [84] was con-
ducted by the Medical Research Council Vitamin Study
Group [85], and tested peri-conceptional folic acid against
multivitamin supplementation in women who had borneBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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a previous child with an NTD (N = 1817). Folic acid sup-
plementation was associated with a 72% reduced risk of
NTDs (RR = 0.28, 95% CI: 0.12–0.71), whereas the mul-
tivitamin supplement had no significant protective effect
[LOE: 1+].
The other meta-analyses and studies we reviewed were
designed to assess the impact on perinatal outcomes of
antenatal administration of folic acid. The review by Pena-
Rosas [86] of 2 RCTs found no associated reduction in
PMR (Additional file 7). Few studies reported stillbirth
incidence, and those that did, reported only non-signifi-
cant reductions in SBR [87] (Additional file 8).
Conclusion
Evidence of the protective effect of peri-conceptual folic
acid supplementation on NTDs (Grade A evidence) sug-
gests that peri-conceptional and antenatal folic acid sup-
plementation offered to all pregnant women, particularly
women with a prior affected pregnancy, and public health
measures including iron-folate distribution or fortifica-
tion of food products, may ensure that women of child-
bearing age have adequate folate intake and consequently
reduce NTDs [88]. Evidence from both Cochrane reviews
and individual studies is weak regarding impact of folic
acid supplementation on stillbirth incidence, and there is
no data on its potential to prevent early miscarriages, ren-
dering our assessment of the evidence for an impact of
peri-conceptional folic acid supplementation on still-
births as merely uncertain. Because the biological path-
way by which folate deficiency could result in stillbirths
arising from severe NTDs is established, and the causal
association of folic acid with NTD prevalence has been
demonstrated, there is a need for rigorous RCTs of peri-
conceptional administration of folic acid powered to
assess stillbirth outcomes. Peri-conceptional administra-
tion would improve the likelihood that folate deficiency
Table 11: Impact of peri-conceptional folic acid supplementation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews & meta-analyses
Lumley et al. 2001 [84] Hungary, Ireland, United Kingdom, 
Israel, Australia, Canada, the former 
USSR, and France.
Meta-analysis (Cochrane). 3 RCTs 
included (N = 7,600 women).
Assessed the effects of increased 
consumption of folate (intervention) 
or multivitamins (controls) on the 
prevalence of neural tube defects 
peri-conceptionally.
SBR: RR = 0.78 (95% CI: 0.34–
1.78) [NS]
[13/3915 vs.16/3685 in 
intervention vs. control groups, 
respectively]
Pena-Rosas and Viteri 2006 [86] Ireland.
Meta-analysis (Cochrane). 2 RCTs 
included (N = 145 participants).
Assessed the efficacy, effectiveness 
and safety of routine antenatal daily or 
intermittent iron supplementation 
with (intervention) or without 
(controls) folic acid during pregnancy 
on the health of mothers and 
newborns.
PMR: RR = 2.50 (95% CI: 0.10, 
59.88) [NS]
[1/77 vs. 0/68 in intervention vs. 
control groups, respectively]
Rumbold et al. 2005 [87]. India, Hungary, United Kingdom, 
Israel, Australia, Canada, the former 
USSR, France, Ireland, Nigeria, 
Nepal.
Meta-analysis (Cochrane). 6 RCTs 
included.
Determined the effectiveness and 
safety of periconceptual/antenatal 
folic acid supplementation + 
multivitamin (intervention), as 
compared to no folic acid/
multivitamin (controls) on the risk of 
spontaneous miscarriage, maternal 
adverse outcomes and fetal and infant 
adverse outcomes.
SBR: RR = 1.03 (95% CI: 0.51–
2.09) [NS]
[16/3511 vs. 15/3372 in 
intervention vs. control groups, 
respectively]
Observational studies
Persad et al. 2002 [125] Canada (Nova Scotia). Birth registry 
data.
Population-based retrospective 
study (before-after comparison). 
Included births and stillbirths with 
open NTDs that occurred from 
1991–2000 in the Nova Scotia Atlee 
Perinatal Database.
Assessed the impact on NTDs after 
the Canadian government fortified 
grain products with folic acid.
Open NTDs: RR = 0.46 (95%
CI: 0.32–0.66, P < 0.001)
Anencephaly: RR = 0.41 (95% CI: 
0.22–0.77, P = 0.004)
[0.93/1000 before vs. 0.38/1000 
births after intervention]BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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is remedied early enough in gestation to act in neural tube
formation.
Iron (or iron-folic acid) supplementation
Background
Anaemia is defined as the reduction in the normal
number of red blood cells and quantity of haemoglobin
in the blood, defined by the WHO as haemoglobin <11 g/
dl [89].
Routine iron supplementation to pregnant women during
pregnancy has been shown to improve biochemical indi-
cators of iron status and to reduce the risk of low maternal
haemoglobin at delivery and at 6 weeks postpartum.
While there is little information on the impact of iron on
functional outcomes, iron (or iron plus folic acid) supple-
mentation is recommended for pregnant women in areas
with endemic iron deficiency [90].
Literature-based evidence
The review of literature identified 2 Cochrane reviews
comprised of 3 RCTs, as well as 2 intervention studies
(Table 12). In their Cochrane meta-analysis which
included just one trial comparing two-thirds of the recom-
mended dose of intravenous iron versus full-dose intrave-
nous iron in iron-deficient women, Reveiz L et al. 2007
[91] reported a non-significant reduction in stillbirth risk
(RR = 0.70, 95% CI: 0.25–1.93 [NS]) among the group
given the two-thirds dose (Additional file 9). As this small
study did not meet the Cochrane quality standards for
assessing effectiveness and stillbirths were not a primary
outcome, this finding may be artifactual [LOE: 1+]. The
most recent Cochrane systematic review of antenatal iron
supplementation by Pena-Rosas et al. [86] summarised 40
trials (N = 12706 women) with either daily or weekly ther-
apy (Additional file 10). Few of the included studies
reported perinatal outcomes or stillbirths, but two trials in
this meta-analysis revealed a non-significant increase in
PMR in the iron/folic acid recipients compared to placebo
(RR = 2.50, 95% CI: 0.10–59.88) [LOE: 1+]
Our review also identified another study of iron supple-
mentation in pregnancy. In The Gambia, Menendez et al
[92] reported a 33% decrease in SBR after supplementing
women with 200 mg oral ferrous sulphate, but furnished
no significance statistics.
Conclusion
Given widespread anaemia during pregnancy, routine
iron supplementation in doses ranging from 60 mg to 300
mg of iron per day is advised during pregnancy for a host
of well-documented maternal benefits (overall Grade B
evidence). The impact of maternal iron supplementation
on stillbirths has not been reported by many studies, how-
ever, and the limited available evidence is mixed, due in
part because most studies are underpowered to detect dif-
ferences. Nevertheless, particularly in areas with high
prevalence of iron deficiency anaemia, iron supplementa-
tion packaged with folic acid is recommended for peri-
conceptual administration for maternal health, but fur-
ther research is needed to define its impact on stillbirths.
Despite some evidence of impact on perinatal mortality,
our overall assessment of the impact of iron or iron-folic
acid supplementation on stillbirths indicates no overt
benefit.
Vitamin A/β-carotene supplementation during pregnancy
Background
Vitamin A is required for fetal tissue growth and mainte-
nance, as well as maternal metabolism; it plays an impor-
tant role in cell differentiation and, therefore,
embryogenesis very early in pregnancy [93,94]. Clinical
and subclinical Vitamin A deficiency is a public health
concern in at least 75 countries worldwide, and contrib-
utes to impaired immune host response, maternal eye
problems including xerophthalmia, night-blindness, as
well as decreased haemoglobin levels and anaemia [95-
97]. Vitamin A deficiency co-exists with iron deficiency in
many countries [98], and is linked with an elevated risk of
LBW, as well as an increased risk of infections (diarrhea,
dysentery, acute respiratory illness) and poor growth in
young infants [99]. Given the potential teratogenic effect
and toxicity of high-dose vitamin A, a variety of vitamin A
interventions (daily supplementation with either low-
dose vitamin A or β-carotene) have been evaluated with
assessment of safety and impact on maternal, newborn
and infant outcomes.
Literature-based evidence
Three Cochrane reviews comprised of 9 RCTs were identi-
fied following the literature search (Table 13). Wiysonge
et al. [100] reviewed 4 trials in their Cochrane review,
which enrolled HIV-infected pregnant women (N = 3033)
(Additional file 11). Vitamin A supplementation had no
effect on stillbirth risk (OR = 0.99, 95% CI: 0.67–1.46)
[LOE: 1++]. Van den Broek et al. [96] performed a
Cochrane review of 5 trials of women who had received
vitamin A in pregnancy (N = 23,426), but only one study
[101], reported perinatal mortality [LOE: 1+] (Additional
file 12). This large cluster RCT of Katz et al. [101] was con-
ducted in Nepal, where married women (N = 43,559
women, N = 17,373 pregnancies, N = 15,987 live births)
were administered weekly doses of retinol equivalents
(7000 mcg Vitamin A or 42 mg all-trans-β-carotene) or
placebo. Although all-cause maternal mortality declined
significantly (RR 0.60, 95% CI: 0.37–0.97), there was no
statistically significant effect on stillbirth in the Vitamin A
group (RR = 1.06, 95% CI: 0.91–1.25) or the beta-caro-
tene group (RR = 1.03, 95% CI: 0.87–1.19) compared to
placebo [LOE: 1+]. A meta-analysis by Rumbold et al. [87]BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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yielded similar findings on the risk of stillbirth associated
with vitamin A supplementation (RR = 1.26, 95% CI:
0.53, 3.01) [LOE: 1++] (Additional file 13).
Conclusion
The existence of a Cochrane review on the subject and sev-
eral strong RCTs allow us to rate the level of evidence as
Grade C [96], but the available evidence suggests no role
of vitamin A in preventing stillbirths. Many of the studies
in the review suffered from design weaknesses, and com-
parability was hampered by differing outcome defini-
tions, suggesting that there is still a need for more rigorous
evidence on this subject. The largest RCT reporting the
impact of vitamin A on stillbirths [101] also indicates no
benefit of Vitamin A for fetal or early infant survival,
although vitamin A does appear to be of benefit to mater-
nal health and survival, and vitamin A deficiencies are
known to co-exist with iron deficiency [98]. Any future
studies of vitamin A supplementation must focus on high-
risk women, assess the most appropriate vitamin type and
dosage, and show that the intervention is both safe for the
mother and fetus, and effective.
Multivitamin/multiple micronutrient supplementation 
during pregnancy
Background
Nutritional deficiencies are common during pregnancy,
particularly in low- and middle-income countries where
the diets of pregnant women are often less nutrient-dense
than those of women in high-income countries. Inade-
Table 12: Impact of antenatal iron supplementation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews & meta-analyses
Pena-Rosas and Viteri 2006 [86] Ireland.
Meta-analysis (Cochrane). 2 RCTs 
included (N = 145 women).
To assess the efficacy, effectiveness 
and safety of routine antenatal daily 
or intermittent iron supplementation 
with (intervention) or without 
(control) folic acid during pregnancy 
on the health of mothers and 
newborns.
PMR: RR = 2.50 (95% CI: 0.10, 
59.88) [NS]
[1/77 vs. 0/68 in intervention vs. 
control groups, respectively]
Reveiz et al. 2007 [91] Tanzania.
Review (Cochrane). 1 RCT 
included.
Administered two-thirds dose 
intravenous (IV) iron vs. full dose IV 
iron by total dose infusion.
SBR: RR = 0.70 (95% CI: 0.25–
1.93) [NS]
[6/248 vs. 9/259 in 2/3rd dose vs. 
full dose groups, respectively]
Intervention studies
Shankar et al. 2008 [104] Indonesia (Lombok).
Cluster-RCT. 262 midwives 
randomly allocated to distribute 
iron and folic acid (N = 15, 486) or 
multiple micronutrients (N = 
15,804) to pregnant women 
through government ANC services.
Assessed daily antenatal 
administration by midwives of iron 
plus folic acid (intervention) or a 
multiple micronutrient supplement 
(comparison) to pregnant women 
through government ANC services. 
Supplements were given from 
enrollment (at any gestational age) to 
90 days post partum.
PMR: RR = 0.89 (95% CI: 0.81–
1.00, P = 0.045)
[535/14239 (37.6/1000) vs. 492/
14532 (33.9/1000) in intervention 
vs. comparison (micronutrient) 
groups, respectively]
PMR (undernourished mothers): 
RR 0.85 (95% CI: 0.73–0.98, P = 
0.022)
PMR (anaemic mothers):
RR = 0.71 (95% CI: 0.58–0.87, P = 
0.001)
SBR: [NS]
[268/14321 (18.7) vs 245/14618 
(16.8) in intervention vs. 
comparison groups, respectively]
Menendez et al. 1994 [92] The Gambia. Rural community-
based trial.
RCT. 18 villages near Farafenni, 
North Bank Division. N = 273 
intervention group, N = 277 
control group.
Multigravid pregnant women who 
had been identified previously by 
TBAs were allocated at random by 
compound of residence to receive 
daily either 200 mg oral FeSO4 (60 
mg elemental iron) or placebo.
SBR: 8/273 (2.9%) vs. 12/277 
(4.3%) in intervention vs. control 
groups, respectively. No statistical 
data.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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quate dietary intake before and during pregnancy may
also pose fetal risks, and could plausibly be compensated
for with appropriate supplementation of missing nutri-
ents. Multiple deficiencies often co-exist, thus supplemen-
tation with multiple nutrients simultaneously may have
an increased, possibly synergistic effect on perinatal out-
comes. Routine maternal nutrient supplementation in
low- and middle-income countries is generally restricted
to provision of iron-folate supplements. Change in prac-
tice toward supplementation with multiple micronutri-
ents (MMN) has been hindered because of a lack of data
about the impact of MMN on fetal and neonatal out-
comes.
Literature-based evidence
The review of literature identified 3 Cochrane reviews,
which included 17 RCTs, and 7 other quasi-experimental
and observational studies (Table 14). Rumbold et al. [87]
undertook a Cochrane review of all RCTs and quasi-RCTs
comparing one or more vitamins with either placebo,
other vitamins, no vitamins or other interventions prior to
conception, peri-conceptionally or in early pregnancy
(<20 weeks' gestation) (Additional file 14). There were no
differences between women taking any vitamins com-
pared with controls (minimal or no vitamins) for total
fetal death (RR = 1.05, 95% CI: 0.95–1.15 [NS]), early or
late miscarriage (RR = 1.08, 95% CI: 0.95–1.24 [NS]) or
stillbirth (RR = 0.85, 95% CI: 0.63–1.14 [NS])  [LOE:
1++]. More recently, Haider and Bhutta [102] undertook
a Cochrane review of the impact of combinations of three
or more micronutrients administered during pregnancy,
including 9 RCTs (N = 15,378 women) (Additional file
15). There was no effect of multiple micronutrient supple-
mentation on perinatal mortality compared to supple-
mentation with two or fewer micronutrients, no
supplementation, or placebo (RR = 1.05, 95% CI: 0.90–
1.23), or iron-folate only (RR = 1.16, 95% CI: 0.95–1.42)
[LOE: 1++]. Say et al. [103] conducted a Cochrane review
on maternal nutrient supplementation and showed a
potentially promising impact of calf blood extract on
reducing PMR, but the sample size was too small to reach
significance (RR = 0.19, 95% CI: 0.01–3.03) [LOE: 1-]
(Additional file 16).
Reporting results of an RCT in Indonesia, Shankar et al.
[104] recorded a borderline lower risk of fetal loss or neo-
natal death (combined outcome) among women given
multiple micronutrients compared with a control group
given iron-folate during pregnancy (RR = 0.89, 95% CI:
0.81–1.00, P = 0.045). In the subset of anaemic mothers,
a statistically significant 29% reduction in combined fetal
loss and neonatal deaths was reported (RR = 0.71, 95%
CI: 0.58–0.87) [LOE: 1++]. In Tanzania, Fawzi et al. [105]
randomised HIV-negative pregnant women (N = 8468) in
their second trimester to receive daily multivitamins
(including multiples of the RDA) or placebo, but found
no evidence of impact on fetal death (4.3% vs. 5% in
Table 13: Impact of vitamin A/β-carotene supplementation on stillbirths and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal outcome
Reviews and meta-analyses
Rumbold et al. 2005 [87] Tanzania, Nepal, Indonesia.
Meta-analysis (Cochrane). 3 
RCTs included.
Assessed the impact on pregnancy 
outcomes of vitamin A supplementation 
+/- multivitamins (intervention #1), 
compared to supplementation with 
placebo +/- multivitamins (controls). 
Also assessed the impact of vitamin A + 
iron + folate (intervention #2) vs. iron + 
folate (controls).
SBR: RR = 1.04 (95% CI: 0.60–1.79) 
[NS] in those supplemented with 
vitamin A (+/- multivitamins) vs. 
those supplemented with placebo (+/
- multivitamins)[1 RCT, N = 11723 
women]
SBR: RR = 1.26 (95% CI: 0.53–3.01) 
[NS] in those supplemented with 
vitamin A + iron + folate vs. those 
supplemented with iron + folate [2 
RCTs, N = 940 women]
van den Broek et al. 2002 [96] Nepal.
Review (Cochrane). 1 RCT 
included.
Assessed the impact on pregnancy 
outcomes of vitamin A (intervention #1) 
and/or β-carotene (intervention #2) 
supplementation vs. placebo (controls).
Fetal death: RR = 1.04 (95% CI: 
0.92–1.17) [NS] in women receiving 
vitamin A vs. controls, respectively.
Fetal death: RR = 1.03 (95% CI: 
0.91–1.16) [NS] in women receiving 
β-carotene vs. controls, respectively.
Wiysonge et al. 2005 [100] South Africa, Tanzania, 
Zimbabwe, Malawi.
Meta-analysis (Cochrane). 4 
RCTs included.
Compared the impact on pregnancy 
outcomes of vitamin A supplementation 
(intervention) vs. no vitamin A 
supplementation (controls).
SBR: OR = 0.99 (95% CI: 0.67–1.46) 
[NS].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Table 14: Impact of multiple micronutrient supplementation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews & meta-analyses
Haider and Bhutta 2006 [102] Bangladesh, Nepal, USA, Guinea-
Bissau, Pakistan, Mexico.
Meta-analysis (Cochrane). 7 RCTs.
To evaluate impact of multiple-
micronutrient supplements in 
pregnancy, including an assessment of 
the risk of excess supplementation and 
potential adverse interactions between 
micronutrients.
PMR: RR = 1.05 (95% CI: 0.90–
1.23) [NS]
[363/6050 vs. 310/5906 in 
intervention vs. control groups, 
respectively].
Rumbold et al. 2005 [87] Hungary, Nigeria, India, UK, USA, 
South Africa, Ireland.
Meta-analysis (Cochrane). 9 RCTs 
included.
Compared the impact of multiple 
micronutrient supplementation 
including folic acid vs. folic acid alone 
on pregnancy outcomes.
SBR: (RR = 0.97 (95% CI: 0.14–
6.88) [NS]
Say et al. 2003 [103] Germany.
Review (Cochrane). 1 RCT included.
Compared the impact of calf blood 
extract vs. placebo on pregnancy 
outcomes.
PMR: RR = 0.19 (95% CI: 0.01–
3.63) [NS]
Intervention studies
Arifeen et al. 2006 [126] Bangladesh.
RCT. Pregnant women (N = 3737) 
with gestational age <14 wks, 
haemoglobin ≥ 80 g/L. N = 1265 
intervention group, N = 1248 
controls.
Assessed the impact of multiple-
micronutrient supplementation in 
reference to different dosages of iron-
folate supplementation on pregnancy 
outcomes.
PMR: RR = 0.99 (95% CI: 0.76–
1.29) [NS]
[52/1224 vs. 114/2513 in 
intervention vs. control groups, 
respectively]
Czeizel et al. 1996 [127] Hungary (Budapest).
RCT, Hungarian Optimal Family 
Planning Programme. N = 5502.
Compared supplementation with 
multivitamins vs. controls given a few 
trace elements periconceptually on 
pregnancy outcome.
SBR: 13.4% vs. 11.4% in 
intervention vs. control groups, 
respectively. (χ2 = 4.82, P = 0.03).
Miscarriage: 10.8% vs. 9.4% in 
intervention vs. control groups, 
respectively [NS] (χ2 = 2.69 P = 
0.10).
Fawzi et al. 2007 [105] Tanzania (Dar es Salaam).
RCT. HIV-negative pregnant women 
(N = 8468) 12–27 wks gestation
Assessed the impact of daily 
multivitamins (multiples of the RDA) vs. 
placebo on pregnancy outcomes.
SBR: RR = 0.87 (95% CI: 0.72–
1.05, P = 0.15) [NS]
[129/4069 (4.3%) vs. 148/4052 
(5.0%) in intervention vs. control 
groups, respectively.]
Fleming et al. 1986 [128] Nigeria.
Quasi-RCT. N = 75 primigravida 
10–26 wks gestation with 
haematocrit value (PCV) ≥ 27% who 
had not yet received treatment.
Assessed the impact of folic acid (5 mg) 
supplementation every 2 wks until the 
last trimester (weekly) vs. placebo on 
pregnancy outcomes. All women 
received anti-malarials and iron 
supplements as part of standard ANC 
at the hospital.
SBR: RR = 0.38 (95% CI: 0.02–
9.03) [NS]
[0/35 vs. 2/40 in intervention vs. 
control groups, respectively].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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intervention vs. control groups, respectively; RR = 0.87;
95% CI: 0.72–1.05; P = 0.15) [LOE: 1++]
New meta-analysis
We conducted an updated meta-analysis, including trials
published since the most recent Cochrane reviews, of the
impact of multiple micronutrient supplementation in
pregnancy (Figure 1). The meta-analysis (9 RCTs, N =
40,222 women, N = 20,277 intervention group, N =
19,945 controls) compared the impact on stillbirths of
multiple micronutrient supplementation during preg-
nancy (intervention) with either iron or iron and folate
Results of a new meta-analysis of impact of multiple micronutrient supplementation during pregnancy on stillbirths Figure 1
Results of a new meta-analysis of impact of multiple micronutrient supplementation during pregnancy on still-
births.
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Shankar et al. 2008 [104] Indonesia (Lombok).
Cluster-RCT. 262 midwives 
randomly allocated to distribute 
multiple micronutrients (N = 
15,804) or iron and folic acid (N = 
15,486) to pregnant women through 
government ANC services.
Assessed daily antenatal administration 
by midwives of a multiple micronutrient 
supplement (intervention) or iron-
folate (comparison) to pregnant 
women through government ANC 
services. Supplements were given from 
enrollment (at any gestation) to 90 days 
post partum.
PMR: RR = 0.89 (95% CI: 0.81–
1.00, P = 0.045)
[535/14239 (37.6/1000) vs. 492/
14532 (33.9/1000) in intervention 
vs. comparison groups, 
respectively]
PMR (undernourished mothers): 
RR = 0.85 (95% CI: 0.73–0.98, P 
= 0.022)
PMR (anaemic mothers):
RR = 0.71 (95% CI: 0.58–0.87, P 
= 0.001)
SBR: [NS]
[268/14321 (18.7) vs. 245/14618 
(16.8) in intervention vs. 
comparison groups, respectively]
Zagre et al. 2007 [129] Niger (Maradi). Rural setting.
Cluster-RCT. 78 villages.
To assess the effects of prenatal 
supplementation with UNIMMAP 
(United Nations International Multiple 
Micronutrient Preparation) compared 
to iron/folic acid (controls) on 
pregnancy outcomes.
SBR (unpublished data): OR = 
1.18 (95% CI = 0.79–1.77) [NS].
[57/1521 vs. 44/1381 in 
intervention vs. control groups, 
respectively].
Friis et al. 2004 [130] Zimbabwe (Harare). ANC clinics.
RCT effectiveness trial. N = 1669 
pregnant women 22–35 wks 
gestation (birth data available for N 
= 1106, of whom 360 (33%) had HIV 
infection).
Compared the impact of daily multiple 
micronutrient supplementation to 
placebo on pregnancy outcomes. All 
women received iron-folate through 
standard ANC.
SBR: [NS]
[4/564 (0.7%) vs. 7/542 (1.3%) in 
intervention vs. control groups, 
respectively, P = 0.39].
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(controls). We found a non-significant trend toward
reduced stillbirths among the intervention group versus
the control group (RR = 0.91, 95% CI: 0.80–1.03).
Conclusion
Despite the clinical importance of remedying nutrient
deficiencies prevalent in low-income countries during the
antenatal period, and several systematic reviews (Grade B
quality evidence), the data provide only some evidence of
impact of multiple micronutrient supplementation on
stillbirth incidence or perinatal mortality. Although the
previous review by Rumbold et al. [87] found no evidence
of impact of multiple micronutrient supplementation on
early or late miscarriage or stillbirth, the new large RCT by
Shankar et al. study [104] and our new meta-analyses pro-
vide evidence suggestive of a small impact on stillbirths.
The Shankar et al study suggests that the potential benefit
of multiple micronutrient supplementation is likely to be
greatest in the most nutrient deficient populations. There
remains insufficient evidence of adverse effects related
antenatal multiple-micronutrient supplementation on
neonatal mortality, although this possibility requires fur-
ther investigation [106]. Any future studies of vitamin
supplementation should focus on women at high risk of
miscarriages and stillbirths, assess the most appropriate
vitamin type and dosage, and test for benefit without risk
of harm to mother or fetus.
Regular magnesium supplementation in pregnancy to 
alleviate deficient states
Background
Magnesium occurs naturally in many foods, making mag-
nesium deficiency rare in healthy individuals eating var-
ied diets [107]. Dietary intake studies during pregnancy,
however, consistently demonstrate that many women,
especially those from economically disadvantaged back-
grounds, have intakes of magnesium below recom-
mended levels [108]. Magnesium plays a role in
regulating body temperature, protein synthesis, and nerve
and muscle function. In laboratory rats, magnesium defi-
ciency was associated with higher systolic blood pressure
and elevated plasma nitrite, suggesting that magnesium
may play a role in controlling blood pressure, though the
mechanism is unknown [109]. Magnesium supplementa-
tion during pregnancy has been associated with a reduced
risk of fetal growth retardation, pre-eclampsia, and
increased birth weight [110], but these findings were gath-
ered from non-randomised, non-controlled studies.
Literature-based evidence
A review of the literature identified one Cochrane review
assessing the potential benefits of magnesium supple-
mentation during pregnancy on pregnancy and neonatal
outcomes (Table 15). Makrides and Crowther [107]
reviewed the impact of magnesium given to all pregnant
women in RCTs and quasi-RCTs (N = 7 trials, N = 2689
women) (Additional file 17). Meta-analysis revealed that
oral magnesium treatment from before the 25th week of
gestation was associated with a lower frequency of pre-
term birth (RR = 0.73, 95% CI: 0.57–0.94), a lower fre-
quency of LBW (RR = 0.67, 95% CI: 0.46–0.96) and fewer
SGA infants (RR = 0.70, 95% CI: 0.53–0.93) compared
with placebo. Only three included trials (N = 1954
women) reported stillbirth outcomes; meta-analysis
revealed no impact of magnesium supplementation on
stillbirth incidence (RR = 1.0, 95% CI: 0.29–3.44). These
findings should be interpreted with caution, as sample
sizes were generally small and the quality of many
included studies was suboptimal [LOE: 1+].
Conclusion
Our overall assessment of the evidence based on studies
was Grade C. Although meta-analysis [107] suggested that
oral magnesium treatment resulted in lower incidence of
pre-term birth, LBW and SGA babies compared with pla-
cebo, the findings were weighted heavily by a trial in Hun-
gary which did not appropriately adjust for cluster
randomisation. With the Hungarian trial excluded, die-
tary magnesium supplementation had no evidence of
impact on pregnancy outcomes. Dietary magnesium sup-
plementation of pregnant women cannot be recom-
mended for routine clinical practice because of the poor
methodological quality of the current evidence. Further
trials are warranted and should be of high quality, includ-
ing concealment of allocation, appropriate unit of ran-
domisation, selection of placebo, blinding of outcome
assessments and minimisation of losses to follow-up.
Because there is no evidence of impact of magnesium sup-
plementation on stillbirth incidence, it cannot be recom-
mended as a strategy to prevent stillbirths at this time.
Table 15: Impact of magnesium supplementation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Makrides M, et al. 2001 [107] 3 RCTs. Austria, Hungary, 
Switzerland.
Compared supplementation with 
different forms of magnesium vs. placebo 
(controls).
SBR: RR = 1.00 (95% CI: 0.29–
3.44) [NS]BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Balanced protein-energy supplementation in pregnancy
Background
Balanced protein-energy supplements, by definition, pro-
vide less than 25% of their total energy content in the
form of protein. A previous observational study [111]
reported that both gestational weight gain and energy
intake were strongly and positively associated with fetal
growth, and possibly associated with a reduced risk of pre-
term birth. Moreover, these associations were stronger in
undernourished women, i.e., those with low pre-preg-
nancy weight-for-height. It is plausible that the improved
fetal growth associated with simple supplementation with
balanced-protein energy supplementation could result in
reduced rates of stillbirth.
Literature-based evidence
Our literature search identified one Cochrane review,
comprised of 6 RCTs, and one quasi-experimental study
(Table 16). The Cochrane review [112] consisted of con-
trolled trials of dietary advice to increase or reduce energy
or protein intake, or of actual protein supplementation or
restriction during pregnancy. Supplementation did not
impact pre-term birth, but significantly reduced risk of
stillbirth and neonatal death. The pooled reductions in
stillbirth rates (RR = 0.55, 95% CI: 0.31–0.97) and neona-
tal deaths (RR = 0.62, 95% CI: 0.37–1.05) of balanced
protein-energy supplementation in pregnancy were based
on four trials and were heavily influenced by a single large
trial in The Gambia [113] (Additional file 18). The Gam-
bian study also included micronutrient supplementation
with balanced protein-energy supplementation; excluding
this single study drastically altered the conclusions of the
meta-analysis, leaving no demonstrable impact. High pro-
tein supplementation in pregnancy was associated with a
non-significant reduction in stillbirth [114] (RR = 0.81,
95% CI: 0.31–2.15); the effects of isocaloric balanced pro-
tein-energy supplementation in pregnancy was non-esti-
mable because the study reported no stillbirths in either
group [115]. The Cochrane review found one study of
nutritional advice during pregnancy, which was associ-
ated with a non-significant reduction in stillbirths [116]
(RR = 0.37, 95% CI: 0.07–1.90). [LOE: 1+].
In rural Punjab, India, a quasi-experimental trial [117],
allocated villages to receive medical care alone, balanced
protein-energy supplementation alone, medical care plus
nutritional supplementation, or no care (controls). Rates
of stillbirth were lower in all intervention villages (P <
0.05 compared to controls), and lowest in villages receiv-
ing nutritional supplementation (P < 0.025) [LOE: 2+].
Conclusion
The evidence for impact of balanced protein-energy sup-
plementation while based on a reasonably large number
of meta-analyses and studies in representative popula-
tions, is heavily weighted by the results of one study
(Grade B evidence). However, there are adequate reported
events of interest i.e. stillbirths/perinatal mortality for one
to draw conclusions of benefit. The body of evidence sug-
gests balanced protein-energy supplementation may be
Table 16: Impact of balanced protein-energy supplementation on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Kramer and Kakuma 2003 [112] Gambia, India, Greece, Chile, 
Colombia, USA.
Meta-analysis (Cochrane). 6 
RCTs included.
Assessed the impact of balanced 
antenatal protein-energy 
supplementation on pregnancy 
outcomes in supplemented 
individuals compared to controls.
SBR: RR = 0.55 (95% CI: 0.31–0.97).
Other intervention studies
Kielmann et al. 1978 [117] India, Rural health research 
centre, Narangwal (Punjab).
Quasi-RCT, clustered by village.
Villages allocated to 1 of 3 service 
groups (medical care: MC), nutrition 
supplementation (NUT), and 
nutrition+medical care (NUT+MC) 
provided by auxiliary health workers 
resident in each village, or control 
villages receiving no care. Outcomes 
measured via longitudinal and cross-
sectional surveys.
SBR: Lower in all service input 
villages combined (P < 0.05 
compared to controls), lowest in 
NUT villages (P < 0.025 compared 
to controls).
PMR: Higher in MC+NUT than 
NUT [NS]
ENMR: Lower in all service input 
villages combined (P < 0.005 
compared to controls). Lowest in 
MC +NUT villages (28/1000 live 
births), intermediate in MC and in 
the NUT villages (37/1000) and high 
in control villages (52.1/1000).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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useful to prevent stillbirths in poor populations at risk of
food insecurity but further well-designed studies are
needed to address the impact on stillbirths.
Summary
Most studies identified in this review were observational;
rigorous RCTs were virtually non-existent. Only rarely did
studies report information about stillbirth reduction, and
rarely did any study report a statistically significant impact
on stillbirth incidence. Many of the interventions that are
being practised during pregnancy are relatively unsup-
ported by evidence, and potential risk factors for antenatal
stillbirth are still being identified (e.g., exposure to indoor
air pollution). Because of this lack of data, it is premature
to recommend most of the interventions that we reviewed
for routine practice.
The nutrition interventions described in this review had
good quality Cochrane reviews and meta-analyses. For
almost every intervention we considered, even where mul-
tiple RCTs and reviews were available, stillbirth and peri-
natal outcomes were often not reported, or reported only
as secondary outcomes, rendering them underpowered to
detect differences in stillbirth rates. To illustrate, many
studies with peri-conceptional folic acid supplementation
evaluated neural tube defects (NTDs) as the main out-
come of interest, yet very few reported stillbirths. Rather
than evidence of no effect, there is no evidence of effect of
folic supplementation; further trials are needed to under-
stand whether folic acid supplementation could bring
about reductions in stillbirth, or just NTDs. Larger RCTs of
all the nutritional interventions we reviewed are needed.
The marginally significant reductions in stillbirths associ-
ated with multiple micronutrient supplementation were
more pronounced among nutrient-deficient women, sug-
gesting that RCTs in deficient populations are most prom-
ising to detect any possible impact on stillbirths.
Social and behavioural factors appear to contribute to the
risk of adverse birth outcomes and stillbirths through
multiple causal pathways, but these risk factors and their
related interventions have attracted the least attention
from researchers of all of the interventions we reviewed in
this series of papers. Reducing rates of FGM, especially
infibulation, could reduce rates of obstructed labour
where infibulation and home birth with unskilled attend-
ants are common, but more studies are needed. Short
inter-pregnancy intervals (IPIs) have been repeatedly
associated with increased stillbirth rates but causation has
not been established, and logistic regression has rendered
associations non-significant, suggesting that better
designed studies to assess inter-conceptional intervals and
contraceptive use, along with qualitative research about
fertility intentions after adverse outcomes, are needed.
Rates of smoking and exposure of women to second-hand
smoke have been increasing throughout low- and middle-
income countries; reducing exposure to smoke, including
combustion particulates and by-products, is of clear ben-
efit for maternal and infant health, but further large stud-
ies are needed to determine whether smoking cessation
reduces stillbirth rates, particularly in low- and middle-
income country settings. Exposure to air pollutants, par-
ticularly to smoke from heating and cooking fires, appears
strongly associated with a woman's risk of stillbirth, but
interventions to reduce exposure that measure birth out-
comes have not yet been tested. Innovative options are
already available for cleaner fuels and smoke-free heating/
cooking methods that would lend themselves to a com-
munity-based intervention trial to test whether these
options could reduce stillbirth rates. Similarly, smokeless
tobacco use has been associated with a statistically signif-
icant higher risk of stillbirths, and this is a subject to be
included in the research agenda. Interventions to reduce
the use of this form of tobacco and their subsequent
impact on perinatal outcomes are lacking. Other social
factors and behaviours before and during pregnancy likely
increase women's risk of antepartum stillbirths; research is
recommended to investigate potential social risk factors
and appropriate interventions to mitigate these risks.
Most of the interventions we explored in this paper rely on
a minimum of an outreach-based model of ANC. ANC is
widely accessed by pregnant women worldwide, even
though complete coverage (at least 4 visits) varies, as do
components and quality of ANC. The health system con-
tact that an ANC visit provides offers an opportunity for
delivery of nutritional interventions (including supple-
ments), behaviour change communication efforts, and
clinical care including identification of high-risk pregnan-
cies [7,118]. Although we found no clear association of
ANC with reductions in stillbirth, there is evidence from
observational studies that having no ANC is associated
with higher rates of stillbirth, likely attributable both to
the specific components and quality of ANC services and
to absolute differences in health status, behaviours, and
exposures among women who access ANC compared with
women who do not.
In low- and middle-income countries, ANC is an essential
platform upon which the prevention of both antenatal
and intrapartum stillbirths depends. ANC provides a con-
tact point to diagnose maternal conditions such as hyper-
tensive disorders leading to fetal growth restriction and
pre-term birth, as well as maternal infections such as syph-
ilis, which may be associated with up to half of all still-
births in high-prevalence settings in southern Africa
[119]. Improving the capacity of ANC services to effec-
tively identify, treat, and monitor these conditions and
diseases [7,118,120] may bring about important reduc-
tions in stillbirth rates.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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Health program planners and providers of ANC should
carefully choose and more routinely document and eval-
uate the services they provide, and explore ways that ANC
could be expanded to include evidence-based interven-
tions that screen for and treat pre-existing and gestational
conditions and infections, such as anemia, syphilis and
hypertensive disorders, that may lead to stillbirths [7].
Health systems strengthening activities are also needed to
provide the necessary referral-level care and community-
Table 18: Summary of evidence grading for all interventions prior to and during pregnancy to prevent stillbirth and perinatal mortality 
reviewed in this paper
Evidence of no or 
negative impact
(leave out of programs)
Uncertain evidence
(need for additional 
research before including 
in programs)
Some evidence
(may include in programs, 
but further evaluation is 
warranted)
Clear evidence
(merits inclusion in 
programs)
Female genital mutilation X
Indoor air pollution X
Smoking cessation X
Smokeless tobacco use X
ANC in pregnancy X
Peri-conceptional folic acid 
supplementation
X
(demonstrated infant 
benefit)
Iron (iron-folate) 
supplementation
X
(demonstrated maternal 
benefit)
Vitamin A/β-carotene 
supplementation
X
Multivitamin/multiple 
micronutrient 
supplementation
X
Magnesium 
supplementation
X
Balanced protein-energy 
supplementation
X
Table 17: Research gaps for care before and during pregnancy to reduce stillbirths
Pilot/cohort studies of interventions
• Trials of alternative cooking technologies or cleaner fuels*
• FGM (especially infibulation) vs. no FGM in non-facility-based births*
• Birth spacing studies, including identification of behavioural/emotional factors after a loss leading to short subsequent IPIs.
Well-designed large RCTs of interventions powered to detect stillbirths
• Effective mutritional interventions, particularly balanced protein-energy supplementation and multiple micronutrient supplementation*
• ANC packages with clearly defined component interventions
• Iron (or iron-folate) supplementation in iron-deficient populations
• Peri-conceptional folic acid supplementation
• Vitamin A in high-risk groups
* Priority areasBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1471-2393/9/S1/S3
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facility linkages to improve outcomes of high-risk preg-
nancies [121].
Research gaps (Table 17)
Of the 12 interventions studied in this paper, none
showed clear evidence of benefit on stillbirths (Table 18),
although several seemed promising. Given widespread
undernutrition in low- and middle-income countries,
interventions to address maternal macronutrient and
micronutrient deficiencies must receive priority, as many
have substantial benefits for maternal health and nutri-
tion outcomes. If these are scaled up in health systems and
population settings, attempts must be made to document
stillbirths as a specific outcome. Some interventions,
including birth spacing and peri-conceptual folic acid and
iron-folate supplementation, benefit maternal health and
prevent perinatal morbidity, but their impact on still-
births has not yet been conclusively measured. Other
interventions like balanced protein-energy supplementa-
tion may reduce stillbirth rates, but further large-scale
effectiveness trials are needed.
The underlying patho-physiological mechanisms are clear
for only some of the causes of antenatal stillbirths; signif-
icant gaps in understanding remain for many others, par-
ticularly those with socio-cultural, behavioural, and/or
psychological components, including substance use/
abuse, elevated exposures to harmful substances shaped
by socioeconomic disparities, and how emotional conse-
quences of an adverse pregnancy outcome shape fertility
intentions and subsequent outcomes. Many other socially
mediated risk factors likely have yet to be identified. A bet-
ter understanding of these mechanisms could lead to for-
mulation of new interventions, health communication
campaigns, and medical treatments to prevent stillbirths.
Conclusion
Complex social behaviours, including maternal diet,
exposure to harmful substances, and care-seeking before
and during pregnancy, influence maternal health and fetal
outcomes. A number of strategies, particularly nutritional
supplementation strategies, have been employed to
improve maternal and fetal outcomes, but the evidence
base for an impact on stillbirths is weak. There is a need
for interventions to be developed and tested in commu-
nity settings for micro- and macronutrient deficiencies,
including anemia and folic acid deficiency. Large trials
sufficiently powered to detect stillbirths are especially
needed to adequately assess the effectiveness of interven-
tions in preventing antenatal stillbirths. Other socially
mediated behaviours, including smoking, exposure to
indoor air pollutants, the practice of FGM, and shortened
inter-pregnancy intervals after an adverse pregnancy out-
come, appear to present an increased risk of stillbirth.
Effective smoking cessation interventions exist, but inter-
ventions are needed to address these other risk factors.
Culturally appropriate behavioural interventions alone or
in combination with pharmacotherapy, should be done
studying impact on stillbirths as well. However, more
safety trials are needed for agents like nicotine replace-
ment therapy and bupropion. Because smokeless tobacco
use has effect on stillbirths at least as much as maternal
smoking, interventions to reduce this form of tobacco use
should also be developed, especially in low-income coun-
tries. These numerous research gaps warrant studies to
identify interventions that alter behaviours and remedy
nutritional deficiencies that place women at risk of still-
birth. ANC provides an important platform for distribut-
ing these interventions, including opportunities to
educate mothers about behavioural changes they can
practice while pregnant to safeguard their and their future
children's health.
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